Capsid protein VP1
OrganismNot specified
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Other combination Heteromer Protein × 300 其他Polymer 360 PDB declaration: 300-meric（300） Consistent with protein copy count | Chain 1； UniProt 580–881 Chain 2； UniProt 70–341 Chain 3； UniProt 342–579 Chain 4； UniProt 2–69 | Fragment：UNP residues 580-881 Fragment：UNP residues 70-341 Fragment：UNP residues 342-579 Fragment：UNP residues 2-69 Non-standard monomer：Yes (specific site not provided by mmCIF) | Poliovirus receptor × 60 （P15151） beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 120 ;beta-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 60 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 120 ;beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 60 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 60 | ELECTRON MICROSCOPY cryo-EM buffer：PBS；pH 7；PBS cryo-EM vitrification conditions：Sample mixed and frozen within 2 minutes.；120 K；Cryogen ETHANE；Sample mixed and frozen within 2 minutes before plunging into liquid ethane. | Resolution 3.70 Å |
| 2 | Other combination Heteromer Protein × 5 其他Polymer 6 PDB declaration: pentameric（5） Consistent with protein copy count | Chain 1； UniProt 580–881 Chain 2； UniProt 70–341 Chain 3； UniProt 342–579 Chain 4； UniProt 2–69 | Fragment：UNP residues 580-881 Fragment：UNP residues 70-341 Fragment：UNP residues 342-579 Fragment：UNP residues 2-69 Non-standard monomer：Yes (specific site not provided by mmCIF) | Poliovirus receptor × 1 （P15151） beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 2 ;beta-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 1 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 2 ;beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 | ELECTRON MICROSCOPY cryo-EM buffer：PBS；pH 7；PBS cryo-EM vitrification conditions：Sample mixed and frozen within 2 minutes.；120 K；Cryogen ETHANE；Sample mixed and frozen within 2 minutes before plunging into liquid ethane. | Resolution 3.70 Å |
| 3 | Other combination Heteromer Protein × 25 其他Polymer 30 PDB declaration: 25-meric（25） Consistent with protein copy count | Chain 1； UniProt 580–881 Chain 2； UniProt 70–341 Chain 3； UniProt 342–579 Chain 4； UniProt 2–69 | Fragment：UNP residues 580-881 Fragment：UNP residues 70-341 Fragment：UNP residues 342-579 Fragment：UNP residues 2-69 Non-standard monomer：Yes (specific site not provided by mmCIF) | Poliovirus receptor × 5 （P15151） beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 10 ;beta-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 5 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 10 ;beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 | ELECTRON MICROSCOPY cryo-EM buffer：PBS；pH 7；PBS cryo-EM vitrification conditions：Sample mixed and frozen within 2 minutes.；120 K；Cryogen ETHANE；Sample mixed and frozen within 2 minutes before plunging into liquid ethane. | Resolution 3.70 Å |
| 4 | Other combination Heteromer Protein × 30 其他Polymer 36 PDB declaration: 30-meric（30） Consistent with protein copy count | Chain 1； UniProt 580–881 Chain 2； UniProt 70–341 Chain 3； UniProt 342–579 Chain 4； UniProt 2–69 | Fragment：UNP residues 580-881 Fragment：UNP residues 70-341 Fragment：UNP residues 342-579 Fragment：UNP residues 2-69 Non-standard monomer：Yes (specific site not provided by mmCIF) | Poliovirus receptor × 6 （P15151） beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 12 ;beta-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 6 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 12 ;beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 6 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 | ELECTRON MICROSCOPY cryo-EM buffer：PBS；pH 7；PBS cryo-EM vitrification conditions：Sample mixed and frozen within 2 minutes.；120 K；Cryogen ETHANE；Sample mixed and frozen within 2 minutes before plunging into liquid ethane. | Resolution 3.70 Å |
| 5 | Other combination Heteromer Protein × 5 其他Polymer 6 PDB declaration: pentameric（5） Consistent with protein copy count | Chain 1； UniProt 580–881 Chain 2； UniProt 70–341 Chain 3； UniProt 342–579 Chain 4； UniProt 2–69 | Fragment：UNP residues 580-881 Fragment：UNP residues 70-341 Fragment：UNP residues 342-579 Fragment：UNP residues 2-69 Non-standard monomer：Yes (specific site not provided by mmCIF) | Poliovirus receptor × 1 （P15151） beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 2 ;beta-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 1 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 2 ;beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose ; × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 | ELECTRON MICROSCOPY cryo-EM buffer：PBS；pH 7；PBS cryo-EM vitrification conditions：Sample mixed and frozen within 2 minutes.；120 K；Cryogen ETHANE；Sample mixed and frozen within 2 minutes before plunging into liquid ethane. | Resolution 3.70 Å |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 3J8F | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1AL2 P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT V1160I Deposited 1997-06-09 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 1, V160I Mutation：CHAIN 1, V160I Mutation：CHAIN 1, V160I | SPH SPHINGOSINE × 60 MYR MYRISTIC ACID × 60 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AL2 P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT V1160I Deposited 1997-06-09 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 1, V160I Mutation：CHAIN 1, V160I Mutation：CHAIN 1, V160I | SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AL2 P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT V1160I Deposited 1997-06-09 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 1, V160I Mutation：CHAIN 1, V160I Mutation：CHAIN 1, V160I | SPH SPHINGOSINE × 5 MYR MYRISTIC ACID × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AL2 P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT V1160I Deposited 1997-06-09 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 1, V160I Mutation：CHAIN 1, V160I Mutation：CHAIN 1, V160I | SPH SPHINGOSINE × 6 MYR MYRISTIC ACID × 6 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AL2 P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT V1160I Deposited 1997-06-09 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 1, V160I Mutation：CHAIN 1, V160I Mutation：CHAIN 1, V160I | SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AL2 P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT V1160I Deposited 1997-06-09 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 6 Protein heterocomplex Heteromer；Protein × 150 PDB declaration: 150-meric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 1, V160I Mutation：CHAIN 1, V160I Mutation：CHAIN 1, V160I | SPH SPHINGOSINE × 30 MYR MYRISTIC ACID × 30 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AR6 P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT V1160I +P1095S Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 1, P95S, V160I Mutation：CHAIN 1, P95S, V160I Mutation：CHAIN 1, P95S, V160I | SPH SPHINGOSINE × 60 MYR MYRISTIC ACID × 60 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AR6 P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT V1160I +P1095S Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 1, P95S, V160I Mutation：CHAIN 1, P95S, V160I Mutation：CHAIN 1, P95S, V160I | SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AR6 P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT V1160I +P1095S Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 1, P95S, V160I Mutation：CHAIN 1, P95S, V160I Mutation：CHAIN 1, P95S, V160I | SPH SPHINGOSINE × 5 MYR MYRISTIC ACID × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AR6 P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT V1160I +P1095S Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 1, P95S, V160I Mutation：CHAIN 1, P95S, V160I Mutation：CHAIN 1, P95S, V160I | SPH SPHINGOSINE × 6 MYR MYRISTIC ACID × 6 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AR6 P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT V1160I +P1095S Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 1, P95S, V160I Mutation：CHAIN 1, P95S, V160I Mutation：CHAIN 1, P95S, V160I | SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AR6 P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT V1160I +P1095S Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 6 Protein heterocomplex Heteromer；Protein × 150 PDB declaration: 150-meric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 1, P95S, V160I Mutation：CHAIN 1, P95S, V160I Mutation：CHAIN 1, P95S, V160I | SPH SPHINGOSINE × 30 MYR MYRISTIC ACID × 30 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AR7 P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT P1095S + H2142Y Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 1, P95S, CHAIN 2, H142Y Mutation：CHAIN 1, P95S, CHAIN 2, H142Y Mutation：CHAIN 1, P95S, CHAIN 2, H142Y | SPH SPHINGOSINE × 60 MYR MYRISTIC ACID × 60 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AR7 P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT P1095S + H2142Y Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 1, P95S, CHAIN 2, H142Y Mutation：CHAIN 1, P95S, CHAIN 2, H142Y Mutation：CHAIN 1, P95S, CHAIN 2, H142Y | SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AR7 P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT P1095S + H2142Y Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 1, P95S, CHAIN 2, H142Y Mutation：CHAIN 1, P95S, CHAIN 2, H142Y Mutation：CHAIN 1, P95S, CHAIN 2, H142Y | SPH SPHINGOSINE × 5 MYR MYRISTIC ACID × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AR7 P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT P1095S + H2142Y Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 1, P95S, CHAIN 2, H142Y Mutation：CHAIN 1, P95S, CHAIN 2, H142Y Mutation：CHAIN 1, P95S, CHAIN 2, H142Y | SPH SPHINGOSINE × 6 MYR MYRISTIC ACID × 6 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AR7 P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT P1095S + H2142Y Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 1, P95S, CHAIN 2, H142Y Mutation：CHAIN 1, P95S, CHAIN 2, H142Y Mutation：CHAIN 1, P95S, CHAIN 2, H142Y | SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AR7 P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT P1095S + H2142Y Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 6 Protein heterocomplex Heteromer；Protein × 150 PDB declaration: 150-meric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 1, P95S, CHAIN 2, H142Y Mutation：CHAIN 1, P95S, CHAIN 2, H142Y Mutation：CHAIN 1, P95S, CHAIN 2, H142Y | SPH SPHINGOSINE × 30 MYR MYRISTIC ACID × 30 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AR8 P1/MAHONEY POLIOVIRUS, MUTANT P1095S Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 1, P95S Mutation：CHAIN 1, P95S Mutation：CHAIN 1, P95S | SPH SPHINGOSINE × 60 MYR MYRISTIC ACID × 60 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AR8 P1/MAHONEY POLIOVIRUS, MUTANT P1095S Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 1, P95S Mutation：CHAIN 1, P95S Mutation：CHAIN 1, P95S | SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AR8 P1/MAHONEY POLIOVIRUS, MUTANT P1095S Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 1, P95S Mutation：CHAIN 1, P95S Mutation：CHAIN 1, P95S | SPH SPHINGOSINE × 5 MYR MYRISTIC ACID × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AR8 P1/MAHONEY POLIOVIRUS, MUTANT P1095S Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 1, P95S Mutation：CHAIN 1, P95S Mutation：CHAIN 1, P95S | SPH SPHINGOSINE × 6 MYR MYRISTIC ACID × 6 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AR8 P1/MAHONEY POLIOVIRUS, MUTANT P1095S Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 1, P95S Mutation：CHAIN 1, P95S Mutation：CHAIN 1, P95S | SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AR8 P1/MAHONEY POLIOVIRUS, MUTANT P1095S Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 6 Protein heterocomplex Heteromer；Protein × 150 PDB declaration: 150-meric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 1, P95S Mutation：CHAIN 1, P95S Mutation：CHAIN 1, P95S | SPH SPHINGOSINE × 30 MYR MYRISTIC ACID × 30 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AR9 P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT H2142Y Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 2, H142Y Mutation：CHAIN 2, H142Y Mutation：CHAIN 2, H142Y | SPH SPHINGOSINE × 60 MYR MYRISTIC ACID × 60 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AR9 P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT H2142Y Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 2, H142Y Mutation：CHAIN 2, H142Y Mutation：CHAIN 2, H142Y | SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AR9 P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT H2142Y Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 2, H142Y Mutation：CHAIN 2, H142Y Mutation：CHAIN 2, H142Y | SPH SPHINGOSINE × 5 MYR MYRISTIC ACID × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AR9 P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT H2142Y Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 2, H142Y Mutation：CHAIN 2, H142Y Mutation：CHAIN 2, H142Y | SPH SPHINGOSINE × 6 MYR MYRISTIC ACID × 6 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AR9 P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT H2142Y Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 2, H142Y Mutation：CHAIN 2, H142Y Mutation：CHAIN 2, H142Y | SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1AR9 P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT H2142Y Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 6 Protein heterocomplex Heteromer；Protein × 150 PDB declaration: 150-meric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Mutation：CHAIN 2, H142Y Mutation：CHAIN 2, H142Y Mutation：CHAIN 2, H142Y | SPH SPHINGOSINE × 30 MYR MYRISTIC ACID × 30 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1ASJ P1/MAHONEY POLIOVIRUS, AT CRYOGENIC TEMPERATURE Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Not recorded | SPH SPHINGOSINE × 60 MYR MYRISTIC ACID × 60 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1ASJ P1/MAHONEY POLIOVIRUS, AT CRYOGENIC TEMPERATURE Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Not recorded | SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1ASJ P1/MAHONEY POLIOVIRUS, AT CRYOGENIC TEMPERATURE Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Not recorded | SPH SPHINGOSINE × 5 MYR MYRISTIC ACID × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1ASJ P1/MAHONEY POLIOVIRUS, AT CRYOGENIC TEMPERATURE Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Not recorded | SPH SPHINGOSINE × 6 MYR MYRISTIC ACID × 6 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1ASJ P1/MAHONEY POLIOVIRUS, AT CRYOGENIC TEMPERATURE Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Not recorded | SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1ASJ P1/MAHONEY POLIOVIRUS, AT CRYOGENIC TEMPERATURE Deposited 1997-08-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 6 Protein heterocomplex Heteromer；Protein × 150 PDB declaration: 150-meric |
Chain 1
579–880（302 aa）
Fragment：VIRUS PROTOMER
Chain 2
69–340（272 aa）
Fragment：VIRUS PROTOMER
Chain 3
341–578（238 aa）
Fragment：VIRUS PROTOMER
|
Not recorded | SPH SPHINGOSINE × 30 MYR MYRISTIC ACID × 30 |
X-RAY DIFFRACTION
X-ray crystallization conditions
microdiaylsis；pH 7.5；VIRUS WAS CRYSTALLIZED BY MICRODIALYSIS AGAINST 10MM PIPES, 0-70 MM NACL, PH 7.5, 2% PEG 400, microdiaylsis
|
Resolution 2.90 Å |
| 1DGI Cryo-EM structure of human poliovirus(serotype 1)complexed with three domain CD155 Deposited 1999-11-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC |
Chain 1
598–880（283 aa）
Chain 2
73–340（268 aa）
Chain 3
341–575（235 aa）
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
POLIOVIRUS WAS INCUBATED WITH CD155-AP FOR 1 HOURS AT 4
DEGREES CELSIUS (277 KELVIN) USING A EIGHT-FOLD EXCESS
OF CD155-AP FOR EACH OF THE SIXTY POSSIBLE BINDING
SITES PER VIRION. AFTER INCUBATION, SAMPLES WERE PREPARED
AS THIN LAYERS OF VITREOUS ICE AND MAINTAINED AT NEAR
LIQUID NITROGEN TEMPERATURE IN THE ELECTRON MICROSCOPE
WITH A GATAN 626 CRYOTRANSFER HOLDER.
X-ray crystallization conditions
ELECTRON MICROSCOPY RECONSTRUCTION；pH 7.5；WARNING: THIS IS AN ELECTRON MICROSCOPY MODEL DEPOSITION. CRYO-EM INFORMATION HAS BEEN INCLUDED IN THE FORM OF REMARK 250 RECORDS AT THE TOP OF THE PDB COORDINATE FILE., pH 7.5, ELECTRON MICROSCOPY RECONSTRUCTION
|
Resolution 22.00 Å |
| 1DGI Cryo-EM structure of human poliovirus(serotype 1)complexed with three domain CD155 Deposited 1999-11-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
598–880（283 aa）
Chain 2
73–340（268 aa）
Chain 3
341–575（235 aa）
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
POLIOVIRUS WAS INCUBATED WITH CD155-AP FOR 1 HOURS AT 4
DEGREES CELSIUS (277 KELVIN) USING A EIGHT-FOLD EXCESS
OF CD155-AP FOR EACH OF THE SIXTY POSSIBLE BINDING
SITES PER VIRION. AFTER INCUBATION, SAMPLES WERE PREPARED
AS THIN LAYERS OF VITREOUS ICE AND MAINTAINED AT NEAR
LIQUID NITROGEN TEMPERATURE IN THE ELECTRON MICROSCOPE
WITH A GATAN 626 CRYOTRANSFER HOLDER.
X-ray crystallization conditions
ELECTRON MICROSCOPY RECONSTRUCTION；pH 7.5；WARNING: THIS IS AN ELECTRON MICROSCOPY MODEL DEPOSITION. CRYO-EM INFORMATION HAS BEEN INCLUDED IN THE FORM OF REMARK 250 RECORDS AT THE TOP OF THE PDB COORDINATE FILE., pH 7.5, ELECTRON MICROSCOPY RECONSTRUCTION
|
Resolution 22.00 Å |
| 1DGI Cryo-EM structure of human poliovirus(serotype 1)complexed with three domain CD155 Deposited 1999-11-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric |
Chain 1
598–880（283 aa）
Chain 2
73–340（268 aa）
Chain 3
341–575（235 aa）
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
POLIOVIRUS WAS INCUBATED WITH CD155-AP FOR 1 HOURS AT 4
DEGREES CELSIUS (277 KELVIN) USING A EIGHT-FOLD EXCESS
OF CD155-AP FOR EACH OF THE SIXTY POSSIBLE BINDING
SITES PER VIRION. AFTER INCUBATION, SAMPLES WERE PREPARED
AS THIN LAYERS OF VITREOUS ICE AND MAINTAINED AT NEAR
LIQUID NITROGEN TEMPERATURE IN THE ELECTRON MICROSCOPE
WITH A GATAN 626 CRYOTRANSFER HOLDER.
X-ray crystallization conditions
ELECTRON MICROSCOPY RECONSTRUCTION；pH 7.5；WARNING: THIS IS AN ELECTRON MICROSCOPY MODEL DEPOSITION. CRYO-EM INFORMATION HAS BEEN INCLUDED IN THE FORM OF REMARK 250 RECORDS AT THE TOP OF THE PDB COORDINATE FILE., pH 7.5, ELECTRON MICROSCOPY RECONSTRUCTION
|
Resolution 22.00 Å |
| 1DGI Cryo-EM structure of human poliovirus(serotype 1)complexed with three domain CD155 Deposited 1999-11-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric |
Chain 1
598–880（283 aa）
Chain 2
73–340（268 aa）
Chain 3
341–575（235 aa）
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
POLIOVIRUS WAS INCUBATED WITH CD155-AP FOR 1 HOURS AT 4
DEGREES CELSIUS (277 KELVIN) USING A EIGHT-FOLD EXCESS
OF CD155-AP FOR EACH OF THE SIXTY POSSIBLE BINDING
SITES PER VIRION. AFTER INCUBATION, SAMPLES WERE PREPARED
AS THIN LAYERS OF VITREOUS ICE AND MAINTAINED AT NEAR
LIQUID NITROGEN TEMPERATURE IN THE ELECTRON MICROSCOPE
WITH A GATAN 626 CRYOTRANSFER HOLDER.
X-ray crystallization conditions
ELECTRON MICROSCOPY RECONSTRUCTION；pH 7.5；WARNING: THIS IS AN ELECTRON MICROSCOPY MODEL DEPOSITION. CRYO-EM INFORMATION HAS BEEN INCLUDED IN THE FORM OF REMARK 250 RECORDS AT THE TOP OF THE PDB COORDINATE FILE., pH 7.5, ELECTRON MICROSCOPY RECONSTRUCTION
|
Resolution 22.00 Å |
| 1DGI Cryo-EM structure of human poliovirus(serotype 1)complexed with three domain CD155 Deposited 1999-11-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
598–880（283 aa）
Chain 2
73–340（268 aa）
Chain 3
341–575（235 aa）
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
POLIOVIRUS WAS INCUBATED WITH CD155-AP FOR 1 HOURS AT 4
DEGREES CELSIUS (277 KELVIN) USING A EIGHT-FOLD EXCESS
OF CD155-AP FOR EACH OF THE SIXTY POSSIBLE BINDING
SITES PER VIRION. AFTER INCUBATION, SAMPLES WERE PREPARED
AS THIN LAYERS OF VITREOUS ICE AND MAINTAINED AT NEAR
LIQUID NITROGEN TEMPERATURE IN THE ELECTRON MICROSCOPE
WITH A GATAN 626 CRYOTRANSFER HOLDER.
X-ray crystallization conditions
ELECTRON MICROSCOPY RECONSTRUCTION；pH 7.5；WARNING: THIS IS AN ELECTRON MICROSCOPY MODEL DEPOSITION. CRYO-EM INFORMATION HAS BEEN INCLUDED IN THE FORM OF REMARK 250 RECORDS AT THE TOP OF THE PDB COORDINATE FILE., pH 7.5, ELECTRON MICROSCOPY RECONSTRUCTION
|
Resolution 22.00 Å |
| 1HXS CRYSTAL STRUCTURE OF MAHONEY STRAIN OF POLIOVIRUS AT 2.2A RESOLUTION Deposited 2001-01-16 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer；Protein × 240 PDB declaration: 240-MERIC |
Chain 1
579–880（302 aa）
Fragment：RESIDUES 579-880
Chain 2
69–340（272 aa）
Fragment：RESIDUES 69-340
Chain 3
341–577（237 aa）
Fragment：RESIDUES 341-577
Chain 4
1–68（68 aa）
Fragment：RESIDUES 1-68
|
Not recorded | PLM PALMITIC ACID × 60 MYR MYRISTIC ACID × 60 |
X-RAY DIFFRACTION
X-ray crystallization conditions
MICRODIALYSIS；pH 7；277 K；10mM Pipes, 50-70 mM NaCl, 5 mM MgCl2, 1mM CaCl2, pH 7.0, MICRODIALYSIS, temperature 277K
|
Resolution 2.20 Å |
| 1HXS CRYSTAL STRUCTURE OF MAHONEY STRAIN OF POLIOVIRUS AT 2.2A RESOLUTION Deposited 2001-01-16 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer；Protein × 4 PDB declaration: tetrameric |
Chain 1
579–880（302 aa）
Fragment：RESIDUES 579-880
Chain 2
69–340（272 aa）
Fragment：RESIDUES 69-340
Chain 3
341–577（237 aa）
Fragment：RESIDUES 341-577
Chain 4
1–68（68 aa）
Fragment：RESIDUES 1-68
|
Not recorded | PLM PALMITIC ACID × 1 MYR MYRISTIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
MICRODIALYSIS；pH 7；277 K；10mM Pipes, 50-70 mM NaCl, 5 mM MgCl2, 1mM CaCl2, pH 7.0, MICRODIALYSIS, temperature 277K
|
Resolution 2.20 Å |
| 1HXS CRYSTAL STRUCTURE OF MAHONEY STRAIN OF POLIOVIRUS AT 2.2A RESOLUTION Deposited 2001-01-16 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Protein homooligomer Homooligomer；Protein × 20 PDB declaration: eicosameric |
Chain 1
579–880（302 aa）
Fragment：RESIDUES 579-880
Chain 2
69–340（272 aa）
Fragment：RESIDUES 69-340
Chain 3
341–577（237 aa）
Fragment：RESIDUES 341-577
Chain 4
1–68（68 aa）
Fragment：RESIDUES 1-68
|
Not recorded | PLM PALMITIC ACID × 5 MYR MYRISTIC ACID × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
MICRODIALYSIS；pH 7；277 K；10mM Pipes, 50-70 mM NaCl, 5 mM MgCl2, 1mM CaCl2, pH 7.0, MICRODIALYSIS, temperature 277K
|
Resolution 2.20 Å |
| 1HXS CRYSTAL STRUCTURE OF MAHONEY STRAIN OF POLIOVIRUS AT 2.2A RESOLUTION Deposited 2001-01-16 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 4 Protein homooligomer Homooligomer；Protein × 24 PDB declaration: 24-meric |
Chain 1
579–880（302 aa）
Fragment：RESIDUES 579-880
Chain 2
69–340（272 aa）
Fragment：RESIDUES 69-340
Chain 3
341–577（237 aa）
Fragment：RESIDUES 341-577
Chain 4
1–68（68 aa）
Fragment：RESIDUES 1-68
|
Not recorded | PLM PALMITIC ACID × 6 MYR MYRISTIC ACID × 6 |
X-RAY DIFFRACTION
X-ray crystallization conditions
MICRODIALYSIS；pH 7；277 K；10mM Pipes, 50-70 mM NaCl, 5 mM MgCl2, 1mM CaCl2, pH 7.0, MICRODIALYSIS, temperature 277K
|
Resolution 2.20 Å |
| 1HXS CRYSTAL STRUCTURE OF MAHONEY STRAIN OF POLIOVIRUS AT 2.2A RESOLUTION Deposited 2001-01-16 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 5 Protein homooligomer Homooligomer；Protein × 4 PDB declaration: tetrameric |
Chain 1
579–880（302 aa）
Fragment：RESIDUES 579-880
Chain 2
69–340（272 aa）
Fragment：RESIDUES 69-340
Chain 3
341–577（237 aa）
Fragment：RESIDUES 341-577
Chain 4
1–68（68 aa）
Fragment：RESIDUES 1-68
|
Not recorded | PLM PALMITIC ACID × 1 MYR MYRISTIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
MICRODIALYSIS；pH 7；277 K；10mM Pipes, 50-70 mM NaCl, 5 mM MgCl2, 1mM CaCl2, pH 7.0, MICRODIALYSIS, temperature 277K
|
Resolution 2.20 Å |
| 1HXS CRYSTAL STRUCTURE OF MAHONEY STRAIN OF POLIOVIRUS AT 2.2A RESOLUTION Deposited 2001-01-16 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 6 Protein homooligomer Homooligomer；Protein × 120 PDB declaration: 120-meric |
Chain 1
579–880（302 aa）
Fragment：RESIDUES 579-880
Chain 2
69–340（272 aa）
Fragment：RESIDUES 69-340
Chain 3
341–577（237 aa）
Fragment：RESIDUES 341-577
Chain 4
1–68（68 aa）
Fragment：RESIDUES 1-68
|
Not recorded | PLM PALMITIC ACID × 30 MYR MYRISTIC ACID × 30 |
X-RAY DIFFRACTION
X-ray crystallization conditions
MICRODIALYSIS；pH 7；277 K；10mM Pipes, 50-70 mM NaCl, 5 mM MgCl2, 1mM CaCl2, pH 7.0, MICRODIALYSIS, temperature 277K
|
Resolution 2.20 Å |
| 1L1N POLIOVIRUS 3C PROTEINASE Deposited 2002-02-19 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1565–1747（183 aa）
Fragment：Residues 1565-1747
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 5；293 K；ammonium sulfate, glycerol, mercaptoethanol, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.10 Å R-free 0.259 |
| 1L1N POLIOVIRUS 3C PROTEINASE Deposited 2002-02-19 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain B
1565–1747（183 aa）
Fragment：Residues 1565-1747
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 5；293 K；ammonium sulfate, glycerol, mercaptoethanol, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.10 Å R-free 0.259 |
| 1NG7 The Solution Structure of the Soluble Domain of Poliovirus 3A Protein Deposited 2002-12-16 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric |
Chain A
1456–1514（59 aa）
Fragment：Poliovirus 3A-N
Chain B
1456–1514（59 aa）
Fragment：Poliovirus 3A-N
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 7；25 K；Ionic strength (raw mmCIF value) 20 mM potassium phosphate, 50 mM NaCl；Pressure ambient
NMR measurement conditions
pH 7；25 K；Ionic strength (raw mmCIF value) 10 mM tris, 50 mM NaCl；Pressure ambient
NMR sample composition
1-3 mM 3A-N U-95% 13C;U-99% 15N; 20mM phosphate buffer NA; 100% D2O | 100% D2O
NMR sample composition
1-3 mM 3A-N U-99% 15N; 20mM phosphate buffer NA; 95% H2O, 5% D2O | 95% H2O/5% D2O
NMR sample composition
1.5 mM 3A-N NA; 1.5 mM 3A-N U-95% 13C;U-99% 15N; 20mM phosphate buffer NA; 100% D2O | 100% D2O
NMR sample composition
2 mM 3A-N U-99% 15N; 10 mM tris buffer NA; 95% H2O, 5% D2O | 95% H2O/5% D2O
NMR sample composition
1-3 mM 3A-N U-95% 13C;U-99% 15N; 20mM phosphate buffer NA; 95% H2O, 5% D2O | 95% H2O/5% D2O
|
Resolution not provided |
| 1NN8 CryoEM structure of poliovirus receptor bound to poliovirus Deposited 2003-01-13 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 420 PDB declaration: 420-MERIC |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–575（235 aa）
Chain 4
1–68（68 aa）
|
Not recorded | MYR MYRISTIC ACID × 60 | ELECTRON MICROSCOPY mmCIF provides none of the parsed conditions | Resolution 15.00 Å |
| 1NN8 CryoEM structure of poliovirus receptor bound to poliovirus Deposited 2003-01-13 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 7 PDB declaration: heptameric |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–575（235 aa）
Chain 4
1–68（68 aa）
|
Not recorded | MYR MYRISTIC ACID × 1 | ELECTRON MICROSCOPY mmCIF provides none of the parsed conditions | Resolution 15.00 Å |
| 1NN8 CryoEM structure of poliovirus receptor bound to poliovirus Deposited 2003-01-13 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 35 PDB declaration: 35-meric |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–575（235 aa）
Chain 4
1–68（68 aa）
|
Not recorded | MYR MYRISTIC ACID × 5 | ELECTRON MICROSCOPY mmCIF provides none of the parsed conditions | Resolution 15.00 Å |
| 1NN8 CryoEM structure of poliovirus receptor bound to poliovirus Deposited 2003-01-13 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 42 PDB declaration: 42-meric |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–575（235 aa）
Chain 4
1–68（68 aa）
|
Not recorded | MYR MYRISTIC ACID × 6 | ELECTRON MICROSCOPY mmCIF provides none of the parsed conditions | Resolution 15.00 Å |
| 1NN8 CryoEM structure of poliovirus receptor bound to poliovirus Deposited 2003-01-13 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 7 PDB declaration: heptameric |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–575（235 aa）
Chain 4
1–68（68 aa）
|
Not recorded | MYR MYRISTIC ACID × 1 | ELECTRON MICROSCOPY mmCIF provides none of the parsed conditions | Resolution 15.00 Å |
| 1PO1 POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R80633, AN INHIBITOR OF VIRAL REPLICATION Deposited 1997-01-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–578（238 aa）
|
Not recorded | J80 (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE × 60 MYR MYRISTIC ACID × 60 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7；pH 7.
|
Resolution 2.90 Å |
| 1PO1 POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R80633, AN INHIBITOR OF VIRAL REPLICATION Deposited 1997-01-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–578（238 aa）
|
Not recorded | J80 (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE × 1 MYR MYRISTIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7；pH 7.
|
Resolution 2.90 Å |
| 1PO1 POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R80633, AN INHIBITOR OF VIRAL REPLICATION Deposited 1997-01-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–578（238 aa）
|
Not recorded | J80 (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE × 5 MYR MYRISTIC ACID × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7；pH 7.
|
Resolution 2.90 Å |
| 1PO1 POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R80633, AN INHIBITOR OF VIRAL REPLICATION Deposited 1997-01-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–578（238 aa）
|
Not recorded | J80 (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE × 6 MYR MYRISTIC ACID × 6 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7；pH 7.
|
Resolution 2.90 Å |
| 1PO1 POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R80633, AN INHIBITOR OF VIRAL REPLICATION Deposited 1997-01-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–578（238 aa）
|
Not recorded | J80 (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE × 1 MYR MYRISTIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7；pH 7.
|
Resolution 2.90 Å |
| 1PO1 POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R80633, AN INHIBITOR OF VIRAL REPLICATION Deposited 1997-01-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 6 Protein heterocomplex Heteromer；Protein × 150 PDB declaration: 150-meric |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–578（238 aa）
|
Not recorded | J80 (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE × 30 MYR MYRISTIC ACID × 30 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7；pH 7.
|
Resolution 2.90 Å |
| 1PO2 POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R77975, AN INHIBITOR OF VIRAL REPLICATION Deposited 1997-01-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–578（238 aa）
|
Not recorded | J77 (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE × 60 MYR MYRISTIC ACID × 60 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7；pH 7.
|
Resolution 2.90 Å |
| 1PO2 POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R77975, AN INHIBITOR OF VIRAL REPLICATION Deposited 1997-01-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–578（238 aa）
|
Not recorded | J77 (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE × 1 MYR MYRISTIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7；pH 7.
|
Resolution 2.90 Å |
| 1PO2 POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R77975, AN INHIBITOR OF VIRAL REPLICATION Deposited 1997-01-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–578（238 aa）
|
Not recorded | J77 (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE × 5 MYR MYRISTIC ACID × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7；pH 7.
|
Resolution 2.90 Å |
| 1PO2 POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R77975, AN INHIBITOR OF VIRAL REPLICATION Deposited 1997-01-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–578（238 aa）
|
Not recorded | J77 (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE × 6 MYR MYRISTIC ACID × 6 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7；pH 7.
|
Resolution 2.90 Å |
| 1PO2 POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R77975, AN INHIBITOR OF VIRAL REPLICATION Deposited 1997-01-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–578（238 aa）
|
Not recorded | J77 (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE × 1 MYR MYRISTIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7；pH 7.
|
Resolution 2.90 Å |
| 1PO2 POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R77975, AN INHIBITOR OF VIRAL REPLICATION Deposited 1997-01-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 6 Protein heterocomplex Heteromer；Protein × 150 PDB declaration: 150-meric |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–578（238 aa）
|
Not recorded | J77 (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE × 30 MYR MYRISTIC ACID × 30 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7；pH 7.
|
Resolution 2.90 Å |
| 1POV ROLE AND MECHANISM OF THE MATURATION CLEAVAGE OF VP0 IN POLIOVIRUS ASSEMBLY: STRUCTURE OF THE EMPTY CAPSID ASSEMBLY INTERMEDIATE AT 2.9 ANGSTROMS RESOLUTION Deposited 1995-08-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer；Protein × 180 PDB declaration: 180-MERIC |
Chain 0
1–340（340 aa）
Chain 1
579–880（302 aa）
Chain 3
341–578（238 aa）
|
Not recorded | MYR MYRISTIC ACID × 60 SPH SPHINGOSINE × 60 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.80 Å |
| 1POV ROLE AND MECHANISM OF THE MATURATION CLEAVAGE OF VP0 IN POLIOVIRUS ASSEMBLY: STRUCTURE OF THE EMPTY CAPSID ASSEMBLY INTERMEDIATE AT 2.9 ANGSTROMS RESOLUTION Deposited 1995-08-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric |
Chain 0
1–340（340 aa）
Chain 1
579–880（302 aa）
Chain 3
341–578（238 aa）
|
Not recorded | MYR MYRISTIC ACID × 1 SPH SPHINGOSINE × 1 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.80 Å |
| 1POV ROLE AND MECHANISM OF THE MATURATION CLEAVAGE OF VP0 IN POLIOVIRUS ASSEMBLY: STRUCTURE OF THE EMPTY CAPSID ASSEMBLY INTERMEDIATE AT 2.9 ANGSTROMS RESOLUTION Deposited 1995-08-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Protein homooligomer Homooligomer；Protein × 15 PDB declaration: pentadecameric |
Chain 0
1–340（340 aa）
Chain 1
579–880（302 aa）
Chain 3
341–578（238 aa）
|
Not recorded | MYR MYRISTIC ACID × 5 SPH SPHINGOSINE × 5 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.80 Å |
| 1POV ROLE AND MECHANISM OF THE MATURATION CLEAVAGE OF VP0 IN POLIOVIRUS ASSEMBLY: STRUCTURE OF THE EMPTY CAPSID ASSEMBLY INTERMEDIATE AT 2.9 ANGSTROMS RESOLUTION Deposited 1995-08-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 4 Protein homooligomer Homooligomer；Protein × 18 PDB declaration: octadecameric |
Chain 0
1–340（340 aa）
Chain 1
579–880（302 aa）
Chain 3
341–578（238 aa）
|
Not recorded | MYR MYRISTIC ACID × 6 SPH SPHINGOSINE × 6 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.80 Å |
| 1POV ROLE AND MECHANISM OF THE MATURATION CLEAVAGE OF VP0 IN POLIOVIRUS ASSEMBLY: STRUCTURE OF THE EMPTY CAPSID ASSEMBLY INTERMEDIATE AT 2.9 ANGSTROMS RESOLUTION Deposited 1995-08-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 5 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric |
Chain 0
1–340（340 aa）
Chain 1
579–880（302 aa）
Chain 3
341–578（238 aa）
|
Not recorded | MYR MYRISTIC ACID × 1 SPH SPHINGOSINE × 1 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.80 Å |
| 1POV ROLE AND MECHANISM OF THE MATURATION CLEAVAGE OF VP0 IN POLIOVIRUS ASSEMBLY: STRUCTURE OF THE EMPTY CAPSID ASSEMBLY INTERMEDIATE AT 2.9 ANGSTROMS RESOLUTION Deposited 1995-08-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 6 Protein homooligomer Homooligomer；Protein × 90 PDB declaration: 90-meric |
Chain 0
1–340（340 aa）
Chain 1
579–880（302 aa）
Chain 3
341–578（238 aa）
|
Not recorded | MYR MYRISTIC ACID × 30 SPH SPHINGOSINE × 30 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.80 Å |
| 1RA6 Poliovirus Polymerase Full Length Apo Structure Deposited 2003-10-31 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1748–2208（461 aa）
Fragment：RNA-directed RNA polymerase (residue 1748-2208)
|
Mutation：L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) | ACY ACETIC ACID × 8 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；sodium acetate, cacodylate, DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.00 Å R-free 0.247 |
| 1RA7 Poliovirus Polymerase with GTP Deposited 2003-10-31 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1748–2208（461 aa）
Fragment：RNA-directed RNA polymerase (residue 1748-2208)
|
Mutation：L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) | GTP GUANOSINE-5'-TRIPHOSPHATE × 1 ACY ACETIC ACID × 7 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；sodium acetate, cacodylate, DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.35 Å R-free 0.259 |
| 1RAJ Poliovirus Polymerase with a 68 residue N-terminal truncation Deposited 2003-10-31 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1816–2208（393 aa）
Fragment：RNA-directed RNA polymerase
|
Mutation：L446A, R455D | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；sodium formate, sodium chloride, HEPES, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.50 Å R-free 0.262 |
| 1RDR POLIOVIRUS 3D POLYMERASE Deposited 1998-04-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1748–2208（461 aa）
|
Not recorded | CA CALCIUM ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.6；pH 6.6
|
Resolution 2.40 Å R-free 0.274 |
| 1TQL POLIOVIRUS POLYMERASE G1A MUTANT Deposited 2004-06-17 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1748–2208（461 aa）
|
Mutation：G1A, L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) | ACY ACETIC ACID × 6 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；sodium acetate, cacodylate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.30 Å R-free 0.262 |
| 1VBD POLIOVIRUS (TYPE 1, MAHONEY STRAIN) COMPLEXED WITH R78206 Deposited 1996-01-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–578（238 aa）
|
Not recorded | J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 60 MYR MYRISTIC ACID × 60 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1VBD POLIOVIRUS (TYPE 1, MAHONEY STRAIN) COMPLEXED WITH R78206 Deposited 1996-01-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–578（238 aa）
|
Not recorded | J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 1 MYR MYRISTIC ACID × 1 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1VBD POLIOVIRUS (TYPE 1, MAHONEY STRAIN) COMPLEXED WITH R78206 Deposited 1996-01-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–578（238 aa）
|
Not recorded | J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 5 MYR MYRISTIC ACID × 5 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1VBD POLIOVIRUS (TYPE 1, MAHONEY STRAIN) COMPLEXED WITH R78206 Deposited 1996-01-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–578（238 aa）
|
Not recorded | J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 6 MYR MYRISTIC ACID × 6 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1VBD POLIOVIRUS (TYPE 1, MAHONEY STRAIN) COMPLEXED WITH R78206 Deposited 1996-01-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–578（238 aa）
|
Not recorded | J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 1 MYR MYRISTIC ACID × 1 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1VBD POLIOVIRUS (TYPE 1, MAHONEY STRAIN) COMPLEXED WITH R78206 Deposited 1996-01-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 6 Protein heterocomplex Heteromer；Protein × 150 PDB declaration: 150-meric |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–578（238 aa）
|
Not recorded | J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 30 MYR MYRISTIC ACID × 30 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1XYR Poliovirus 135S cell entry intermediate Deposited 2004-11-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer；Protein × 420 PDB declaration: 420-MERIC |
Chain 1
649–880（232 aa）
Fragment：residues 649-880
Chain 2
96–332（237 aa）
Fragment：residues 96-332
Chain 3
390–571（182 aa）
Fragment：residues 390-571
Chain 5
341–352（12 aa）
Fragment：residues 341-352
Chain 6
354–389（36 aa）
Fragment：residues 354-389
Chain 7
81–94（14 aa）
Fragment：residues 81-94
Chain 8
620–630（11 aa）
Fragment：residues 620-630
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20mM HEPES, 2mM CaCl2；pH 7.4；20mM HEPES, 2mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE；Plunge freezing into liquid ethane
|
Resolution 11.00 Å |
| 1XYR Poliovirus 135S cell entry intermediate Deposited 2004-11-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer；Protein × 7 PDB declaration: heptameric |
Chain 1
649–880（232 aa）
Fragment：residues 649-880
Chain 2
96–332（237 aa）
Fragment：residues 96-332
Chain 3
390–571（182 aa）
Fragment：residues 390-571
Chain 5
341–352（12 aa）
Fragment：residues 341-352
Chain 6
354–389（36 aa）
Fragment：residues 354-389
Chain 7
81–94（14 aa）
Fragment：residues 81-94
Chain 8
620–630（11 aa）
Fragment：residues 620-630
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20mM HEPES, 2mM CaCl2；pH 7.4；20mM HEPES, 2mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE；Plunge freezing into liquid ethane
|
Resolution 11.00 Å |
| 1XYR Poliovirus 135S cell entry intermediate Deposited 2004-11-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein homooligomer Homooligomer；Protein × 35 PDB declaration: 35-meric |
Chain 1
649–880（232 aa）
Fragment：residues 649-880
Chain 2
96–332（237 aa）
Fragment：residues 96-332
Chain 3
390–571（182 aa）
Fragment：residues 390-571
Chain 5
341–352（12 aa）
Fragment：residues 341-352
Chain 6
354–389（36 aa）
Fragment：residues 354-389
Chain 7
81–94（14 aa）
Fragment：residues 81-94
Chain 8
620–630（11 aa）
Fragment：residues 620-630
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20mM HEPES, 2mM CaCl2；pH 7.4；20mM HEPES, 2mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE；Plunge freezing into liquid ethane
|
Resolution 11.00 Å |
| 1XYR Poliovirus 135S cell entry intermediate Deposited 2004-11-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein homooligomer Homooligomer；Protein × 42 PDB declaration: 42-meric |
Chain 1
649–880（232 aa）
Fragment：residues 649-880
Chain 2
96–332（237 aa）
Fragment：residues 96-332
Chain 3
390–571（182 aa）
Fragment：residues 390-571
Chain 5
341–352（12 aa）
Fragment：residues 341-352
Chain 6
354–389（36 aa）
Fragment：residues 354-389
Chain 7
81–94（14 aa）
Fragment：residues 81-94
Chain 8
620–630（11 aa）
Fragment：residues 620-630
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20mM HEPES, 2mM CaCl2；pH 7.4；20mM HEPES, 2mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE；Plunge freezing into liquid ethane
|
Resolution 11.00 Å |
| 1XYR Poliovirus 135S cell entry intermediate Deposited 2004-11-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein homooligomer Homooligomer；Protein × 7 PDB declaration: heptameric |
Chain 1
649–880（232 aa）
Fragment：residues 649-880
Chain 2
96–332（237 aa）
Fragment：residues 96-332
Chain 3
390–571（182 aa）
Fragment：residues 390-571
Chain 5
341–352（12 aa）
Fragment：residues 341-352
Chain 6
354–389（36 aa）
Fragment：residues 354-389
Chain 7
81–94（14 aa）
Fragment：residues 81-94
Chain 8
620–630（11 aa）
Fragment：residues 620-630
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20mM HEPES, 2mM CaCl2；pH 7.4；20mM HEPES, 2mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE；Plunge freezing into liquid ethane
|
Resolution 11.00 Å |
| 2BBP NMR structures of the peptide linked to the genome (VPg) of poliovirus Deposited 2005-10-17 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1544–1565（22 aa）
Fragment：residues 1-22
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 7.2；283 K；Ionic strength (raw mmCIF value) 10 mM；Pressure 1
NMR sample composition
3.7 mM peptide, 10 mM Na phosphate buffer, pH 7.2, DSS, 10% D20, 90% H2O | 10% D20, 90% H2O
|
Resolution not provided |
| 2IJD Crystal Structure of the Poliovirus Precursor Protein 3CD Deposited 2006-09-29 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric |
Chain 1
1565–2208（644 aa）
|
Mutation：E55A, D58A, E63A, C147A, L629D, R638D | ZN ZINC ION × 2 SO4 SULFATE ION × 8 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 7；293 K；2 M ammonium sulfate, 0.1 M HEPES, 0.3% Jeffamine M600, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 3.40 Å R-free 0.231 |
| 2IJD Crystal Structure of the Poliovirus Precursor Protein 3CD Deposited 2006-09-29 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric |
Chain 2
1565–2208（644 aa）
|
Mutation：E55A, D58A, E63A, C147A, L629D, R638D | ZN ZINC ION × 2 SO4 SULFATE ION × 8 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 7；293 K；2 M ammonium sulfate, 0.1 M HEPES, 0.3% Jeffamine M600, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 3.40 Å R-free 0.231 |
| 2IJF Crystal Structure of the Poliovirus RNA-Dependent RNA Polymerase Fidelity Mutant 3Dpol G64S Deposited 2006-09-29 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1748–2208（461 aa）
|
Mutation：G64S, L446D, R455D | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 7；293 K；2M sodium acetate, 0.1 M HEPES, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 3.00 Å R-free 0.244 |
| 2ILY Crystal structure of poliovirus polymerase complexed with ATP and Mg2+ Deposited 2006-10-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1748–2208（461 aa）
Fragment：RNA-directed RNA polymerase, residues 461-1748
|
Mutation：L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) | NA SODIUM ION × 1 ATP ADENOSINE-5'-TRIPHOSPHATE × 1 ACY ACETIC ACID × 7 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；sodium acetate, cacodylate, dtt, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.60 Å R-free 0.250 |
| 2ILZ Crystal structure of poliovirus polymerase complexed with GTP and Mn2+ Deposited 2006-10-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1748–2208（461 aa）
Fragment：RNA-directed RNA polymerase, residues 1748-2208
|
Mutation：L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) | MN MANGANESE (II) ION × 2 NA SODIUM ION × 2 GTP GUANOSINE-5'-TRIPHOSPHATE × 1 ACY ACETIC ACID × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；sodium acetate, cacodylate, dtt, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.50 Å R-free 0.255 |
| 2IM0 Crystal structure of poliovirus polymerase complexed with CTP and Mg2+ Deposited 2006-10-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1748–2208（461 aa）
Fragment：RNA-directed RNA polymerase, residues 1748-2208
|
Mutation：L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) | NA SODIUM ION × 1 CTP CYTIDINE-5'-TRIPHOSPHATE × 1 ACY ACETIC ACID × 7 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；sodium acetate, cacodylate, dtt, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.25 Å R-free 0.260 |
| 2IM1 Crystal structure of poliovirus polymerase complexed with CTP and Mn2+ Deposited 2006-10-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1748–2208（461 aa）
Fragment：RNA-directed RNA polymerase, residues 1748-2208
|
Mutation：L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) | MN MANGANESE (II) ION × 3 NA SODIUM ION × 1 CTP CYTIDINE-5'-TRIPHOSPHATE × 1 ACY ACETIC ACID × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；sodium acetate, cacodylate, DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.50 Å R-free 0.268 |
| 2IM2 Crystal structure of poliovirus polymerase complexed with UTP and Mg2+ Deposited 2006-10-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1748–2208（461 aa）
Fragment：RNA-directed RNA polymerase, residues 1748-2208
|
Mutation：L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) | NA SODIUM ION × 1 UTP URIDINE 5'-TRIPHOSPHATE × 1 ACY ACETIC ACID × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；sodium acetate, cacodylate, DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.35 Å R-free 0.267 |
| 2IM3 Crystal structure of poliovirus polymerase complexed with UTP and Mn2+ Deposited 2006-10-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1748–2208（461 aa）
Fragment：RNA-directed RNA polymerase, residues 1748-2208
|
Mutation：L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) | MN MANGANESE (II) ION × 2 NA SODIUM ION × 1 UTP URIDINE 5'-TRIPHOSPHATE × 1 ACY ACETIC ACID × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；sodium acetate, cacodylate, DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.60 Å R-free 0.269 |
| 2PLV STRUCTURAL FACTORS THAT CONTROL CONFORMATIONAL TRANSITIONS AND SEROTYPE SPECIFICITY IN TYPE 3 POLIOVIRUS Deposited 1989-10-17 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer；Protein × 240 PDB declaration: 240-MERIC |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–578（238 aa）
Chain 4
1–68（68 aa）
|
Not recorded | SPH SPHINGOSINE × 60 MYR MYRISTIC ACID × 60 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.88 Å |
| 2PLV STRUCTURAL FACTORS THAT CONTROL CONFORMATIONAL TRANSITIONS AND SEROTYPE SPECIFICITY IN TYPE 3 POLIOVIRUS Deposited 1989-10-17 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer；Protein × 4 PDB declaration: tetrameric |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–578（238 aa）
Chain 4
1–68（68 aa）
|
Not recorded | SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.88 Å |
| 2PLV STRUCTURAL FACTORS THAT CONTROL CONFORMATIONAL TRANSITIONS AND SEROTYPE SPECIFICITY IN TYPE 3 POLIOVIRUS Deposited 1989-10-17 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Protein homooligomer Homooligomer；Protein × 20 PDB declaration: eicosameric |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–578（238 aa）
Chain 4
1–68（68 aa）
|
Not recorded | SPH SPHINGOSINE × 5 MYR MYRISTIC ACID × 5 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.88 Å |
| 2PLV STRUCTURAL FACTORS THAT CONTROL CONFORMATIONAL TRANSITIONS AND SEROTYPE SPECIFICITY IN TYPE 3 POLIOVIRUS Deposited 1989-10-17 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 4 Protein homooligomer Homooligomer；Protein × 24 PDB declaration: 24-meric |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–578（238 aa）
Chain 4
1–68（68 aa）
|
Not recorded | SPH SPHINGOSINE × 6 MYR MYRISTIC ACID × 6 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.88 Å |
| 2PLV STRUCTURAL FACTORS THAT CONTROL CONFORMATIONAL TRANSITIONS AND SEROTYPE SPECIFICITY IN TYPE 3 POLIOVIRUS Deposited 1989-10-17 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 5 Protein homooligomer Homooligomer；Protein × 4 PDB declaration: tetrameric |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–578（238 aa）
Chain 4
1–68（68 aa）
|
Not recorded | SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.88 Å |
| 2PLV STRUCTURAL FACTORS THAT CONTROL CONFORMATIONAL TRANSITIONS AND SEROTYPE SPECIFICITY IN TYPE 3 POLIOVIRUS Deposited 1989-10-17 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 6 Protein homooligomer Homooligomer；Protein × 120 PDB declaration: 120-meric |
Chain 1
579–880（302 aa）
Chain 2
69–340（272 aa）
Chain 3
341–578（238 aa）
Chain 4
1–68（68 aa）
|
Not recorded | SPH SPHINGOSINE × 30 MYR MYRISTIC ACID × 30 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.88 Å |
| 3EPC CryoEM structure of poliovirus receptor bound to poliovirus type 1 Deposited 2008-09-29 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC |
Chain 1
599–881（283 aa）
Chain 2
74–341（268 aa）
Chain 3
342–576（235 aa）
Chain 4
2–69（68 aa）
|
Not recorded | SPH SPHINGOSINE × 60 MYR MYRISTIC ACID × 60 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5；10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 8.00 Å |
| 3EPC CryoEM structure of poliovirus receptor bound to poliovirus type 1 Deposited 2008-09-29 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
599–881（283 aa）
Chain 2
74–341（268 aa）
Chain 3
342–576（235 aa）
Chain 4
2–69（68 aa）
|
Not recorded | SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5；10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 8.00 Å |
| 3EPC CryoEM structure of poliovirus receptor bound to poliovirus type 1 Deposited 2008-09-29 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric |
Chain 1
599–881（283 aa）
Chain 2
74–341（268 aa）
Chain 3
342–576（235 aa）
Chain 4
2–69（68 aa）
|
Not recorded | SPH SPHINGOSINE × 5 MYR MYRISTIC ACID × 5 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5；10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 8.00 Å |
| 3EPC CryoEM structure of poliovirus receptor bound to poliovirus type 1 Deposited 2008-09-29 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric |
Chain 1
599–881（283 aa）
Chain 2
74–341（268 aa）
Chain 3
342–576（235 aa）
Chain 4
2–69（68 aa）
|
Not recorded | SPH SPHINGOSINE × 6 MYR MYRISTIC ACID × 6 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5；10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 8.00 Å |
| 3EPC CryoEM structure of poliovirus receptor bound to poliovirus type 1 Deposited 2008-09-29 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
599–881（283 aa）
Chain 2
74–341（268 aa）
Chain 3
342–576（235 aa）
Chain 4
2–69（68 aa）
|
Not recorded | SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5；10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 8.00 Å |
| 3IYB Poliovirus early RNA-release intermediate Deposited 2009-07-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-meric |
Chain 1
647–881（235 aa）
Chain 4
97–341（245 aa）
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl；pH 7.4；20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs；Cryogen ETHANE
|
Resolution 10.00 Å |
| 3IYB Poliovirus early RNA-release intermediate Deposited 2009-07-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
647–881（235 aa）
Chain 4
97–341（245 aa）
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl；pH 7.4；20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs；Cryogen ETHANE
|
Resolution 10.00 Å |
| 3IYB Poliovirus early RNA-release intermediate Deposited 2009-07-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric |
Chain 1
647–881（235 aa）
Chain 4
97–341（245 aa）
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl；pH 7.4；20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs；Cryogen ETHANE
|
Resolution 10.00 Å |
| 3IYB Poliovirus early RNA-release intermediate Deposited 2009-07-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric |
Chain 1
647–881（235 aa）
Chain 4
97–341（245 aa）
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl；pH 7.4；20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs；Cryogen ETHANE
|
Resolution 10.00 Å |
| 3IYB Poliovirus early RNA-release intermediate Deposited 2009-07-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
647–881（235 aa）
Chain 4
97–341（245 aa）
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl；pH 7.4；20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs；Cryogen ETHANE
|
Resolution 10.00 Å |
| 3IYC Poliovirus late RNA-release intermediate Deposited 2009-07-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-meric |
Chain 1
647–881（235 aa）
Chain 4
97–341（245 aa）
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl；pH 7.4；20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs；Cryogen ETHANE
|
Resolution 10.00 Å |
| 3IYC Poliovirus late RNA-release intermediate Deposited 2009-07-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
647–881（235 aa）
Chain 4
97–341（245 aa）
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl；pH 7.4；20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs；Cryogen ETHANE
|
Resolution 10.00 Å |
| 3IYC Poliovirus late RNA-release intermediate Deposited 2009-07-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric |
Chain 1
647–881（235 aa）
Chain 4
97–341（245 aa）
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl；pH 7.4；20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs；Cryogen ETHANE
|
Resolution 10.00 Å |
| 3IYC Poliovirus late RNA-release intermediate Deposited 2009-07-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric |
Chain 1
647–881（235 aa）
Chain 4
97–341（245 aa）
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl；pH 7.4；20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs；Cryogen ETHANE
|
Resolution 10.00 Å |
| 3IYC Poliovirus late RNA-release intermediate Deposited 2009-07-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
647–881（235 aa）
Chain 4
97–341（245 aa）
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl；pH 7.4；20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs；Cryogen ETHANE
|
Resolution 10.00 Å |
| 3J3O Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 160S Poliovirus and C3-Fab Complex Deposited 2013-04-10 | Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 420 PDB declaration: 420-MERIC |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–579（238 aa）
Fragment：UNP residues 342-579
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Not recorded | SPH SPHINGOSINE × 60 MYR MYRISTIC ACID × 60 |
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM Tris, 2 mM CaCl2；pH 7.5；20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunging；Cryogen ETHANE；Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
|
Resolution 11.10 Å |
| 3J3O Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 160S Poliovirus and C3-Fab Complex Deposited 2013-04-10 | Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 7 PDB declaration: heptameric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–579（238 aa）
Fragment：UNP residues 342-579
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Not recorded | SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM Tris, 2 mM CaCl2；pH 7.5；20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunging；Cryogen ETHANE；Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
|
Resolution 11.10 Å |
| 3J3O Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 160S Poliovirus and C3-Fab Complex Deposited 2013-04-10 | Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 35 PDB declaration: 35-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–579（238 aa）
Fragment：UNP residues 342-579
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Not recorded | SPH SPHINGOSINE × 5 MYR MYRISTIC ACID × 5 |
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM Tris, 2 mM CaCl2；pH 7.5；20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunging；Cryogen ETHANE；Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
|
Resolution 11.10 Å |
| 3J3O Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 160S Poliovirus and C3-Fab Complex Deposited 2013-04-10 | Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 42 PDB declaration: 42-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–579（238 aa）
Fragment：UNP residues 342-579
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Not recorded | SPH SPHINGOSINE × 6 MYR MYRISTIC ACID × 6 |
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM Tris, 2 mM CaCl2；pH 7.5；20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunging；Cryogen ETHANE；Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
|
Resolution 11.10 Å |
| 3J3O Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 160S Poliovirus and C3-Fab Complex Deposited 2013-04-10 | Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 7 PDB declaration: heptameric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–579（238 aa）
Fragment：UNP residues 342-579
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Not recorded | SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM Tris, 2 mM CaCl2；pH 7.5；20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunging；Cryogen ETHANE；Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
|
Resolution 11.10 Å |
| 3J3P Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 135S Poliovirus and C3-Fab Complex Deposited 2013-04-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–579（238 aa）
Fragment：UNP residues 342-579
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM Tris, 2 mM CaCl2；pH 7.5；20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunging；Cryogen ETHANE；Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
|
Resolution 9.10 Å |
| 3J3P Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 135S Poliovirus and C3-Fab Complex Deposited 2013-04-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–579（238 aa）
Fragment：UNP residues 342-579
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM Tris, 2 mM CaCl2；pH 7.5；20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunging；Cryogen ETHANE；Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
|
Resolution 9.10 Å |
| 3J3P Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 135S Poliovirus and C3-Fab Complex Deposited 2013-04-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–579（238 aa）
Fragment：UNP residues 342-579
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM Tris, 2 mM CaCl2；pH 7.5；20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunging；Cryogen ETHANE；Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
|
Resolution 9.10 Å |
| 3J3P Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 135S Poliovirus and C3-Fab Complex Deposited 2013-04-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–579（238 aa）
Fragment：UNP residues 342-579
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM Tris, 2 mM CaCl2；pH 7.5；20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunging；Cryogen ETHANE；Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
|
Resolution 9.10 Å |
| 3J3P Conformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron Microscopy: 135S Poliovirus and C3-Fab Complex Deposited 2013-04-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–579（238 aa）
Fragment：UNP residues 342-579
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM Tris, 2 mM CaCl2；pH 7.5；20 mM Tris, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunging；Cryogen ETHANE；Vitrification carried out in ambient atmosphere. Ethane cooled by liquid nitrogen.
|
Resolution 9.10 Å |
| 3J48 Cryo-EM structure of Poliovirus 135S particles Deposited 2013-06-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer；Protein × 180 PDB declaration: 180-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–579（238 aa）
Fragment：UNP residues 342-579
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM HEPES, 2 mM CaCl2；pH 7.4；20 mM HEPES, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunge freezing into liquid ethane；90 K；Cryogen ETHANE；Blotted manually in ambient atmosphere before plunging into ethane cooled by liquid nitrogen.
|
Resolution 5.50 Å |
| 3J48 Cryo-EM structure of Poliovirus 135S particles Deposited 2013-06-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–579（238 aa）
Fragment：UNP residues 342-579
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM HEPES, 2 mM CaCl2；pH 7.4；20 mM HEPES, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunge freezing into liquid ethane；90 K；Cryogen ETHANE；Blotted manually in ambient atmosphere before plunging into ethane cooled by liquid nitrogen.
|
Resolution 5.50 Å |
| 3J48 Cryo-EM structure of Poliovirus 135S particles Deposited 2013-06-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein homooligomer Homooligomer；Protein × 15 PDB declaration: pentadecameric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–579（238 aa）
Fragment：UNP residues 342-579
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM HEPES, 2 mM CaCl2；pH 7.4；20 mM HEPES, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunge freezing into liquid ethane；90 K；Cryogen ETHANE；Blotted manually in ambient atmosphere before plunging into ethane cooled by liquid nitrogen.
|
Resolution 5.50 Å |
| 3J48 Cryo-EM structure of Poliovirus 135S particles Deposited 2013-06-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein homooligomer Homooligomer；Protein × 18 PDB declaration: octadecameric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–579（238 aa）
Fragment：UNP residues 342-579
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM HEPES, 2 mM CaCl2；pH 7.4；20 mM HEPES, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunge freezing into liquid ethane；90 K；Cryogen ETHANE；Blotted manually in ambient atmosphere before plunging into ethane cooled by liquid nitrogen.
|
Resolution 5.50 Å |
| 3J48 Cryo-EM structure of Poliovirus 135S particles Deposited 2013-06-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–579（238 aa）
Fragment：UNP residues 342-579
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20 mM HEPES, 2 mM CaCl2；pH 7.4；20 mM HEPES, 2 mM CaCl2
cryo-EM vitrification conditions
Blotted manually before plunge freezing into liquid ethane；90 K；Cryogen ETHANE；Blotted manually in ambient atmosphere before plunging into ethane cooled by liquid nitrogen.
|
Resolution 5.50 Å |
| 3J9F Poliovirus complexed with soluble, deglycosylated poliovirus receptor (Pvr) at 4 degrees C Deposited 2015-01-15 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer；Protein × 420 PDB declaration: 420-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–579（238 aa）
Fragment：UNP residues 342-579
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 60 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 60 |
ELECTRON MICROSCOPY
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 9.00 Å |
| 3J9F Poliovirus complexed with soluble, deglycosylated poliovirus receptor (Pvr) at 4 degrees C Deposited 2015-01-15 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Heteromer；Protein × 7 PDB declaration: heptameric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–579（238 aa）
Fragment：UNP residues 342-579
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 |
ELECTRON MICROSCOPY
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 9.00 Å |
| 3J9F Poliovirus complexed with soluble, deglycosylated poliovirus receptor (Pvr) at 4 degrees C Deposited 2015-01-15 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Other combination Heteromer；Protein × 35 PDB declaration: 35-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–579（238 aa）
Fragment：UNP residues 342-579
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 |
ELECTRON MICROSCOPY
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 9.00 Å |
| 3J9F Poliovirus complexed with soluble, deglycosylated poliovirus receptor (Pvr) at 4 degrees C Deposited 2015-01-15 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Other combination Heteromer；Protein × 42 PDB declaration: 42-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–579（238 aa）
Fragment：UNP residues 342-579
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 6 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 |
ELECTRON MICROSCOPY
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 9.00 Å |
| 3J9F Poliovirus complexed with soluble, deglycosylated poliovirus receptor (Pvr) at 4 degrees C Deposited 2015-01-15 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Other combination Heteromer；Protein × 7 PDB declaration: heptameric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–579（238 aa）
Fragment：UNP residues 342-579
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 |
ELECTRON MICROSCOPY
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 9.00 Å |
| 3JBC Complex of Poliovirus with VHH PVSP29F Deposited 2015-08-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–578（237 aa）
Fragment：UNP residues 342-578
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 60 |
ELECTRON MICROSCOPY
cryo-EM buffer
PBS；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
154 K；Cryogen ETHANE；Plunged into liquid ethane (homemade plunger).
|
Resolution 5.60 Å |
| 3JBC Complex of Poliovirus with VHH PVSP29F Deposited 2015-08-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–578（237 aa）
Fragment：UNP residues 342-578
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
PBS；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
154 K；Cryogen ETHANE；Plunged into liquid ethane (homemade plunger).
|
Resolution 5.60 Å |
| 3JBC Complex of Poliovirus with VHH PVSP29F Deposited 2015-08-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–578（237 aa）
Fragment：UNP residues 342-578
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 5 |
ELECTRON MICROSCOPY
cryo-EM buffer
PBS；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
154 K；Cryogen ETHANE；Plunged into liquid ethane (homemade plunger).
|
Resolution 5.60 Å |
| 3JBC Complex of Poliovirus with VHH PVSP29F Deposited 2015-08-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–578（237 aa）
Fragment：UNP residues 342-578
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 6 |
ELECTRON MICROSCOPY
cryo-EM buffer
PBS；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
154 K；Cryogen ETHANE；Plunged into liquid ethane (homemade plunger).
|
Resolution 5.60 Å |
| 3JBC Complex of Poliovirus with VHH PVSP29F Deposited 2015-08-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–578（237 aa）
Fragment：UNP residues 342-578
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
PBS；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
154 K；Cryogen ETHANE；Plunged into liquid ethane (homemade plunger).
|
Resolution 5.60 Å |
| 3JBD Complex of poliovirus with VHH PVSP6A Deposited 2015-08-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-MERIC |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–578（237 aa）
Fragment：UNP residues 342-578
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 60 |
ELECTRON MICROSCOPY
cryo-EM buffer
PBS；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
2 second blot；154 K；Cryogen ETHANE；Blotted for 2 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.70 Å |
| 3JBD Complex of poliovirus with VHH PVSP6A Deposited 2015-08-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–578（237 aa）
Fragment：UNP residues 342-578
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
PBS；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
2 second blot；154 K；Cryogen ETHANE；Blotted for 2 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.70 Å |
| 3JBD Complex of poliovirus with VHH PVSP6A Deposited 2015-08-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–578（237 aa）
Fragment：UNP residues 342-578
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 5 |
ELECTRON MICROSCOPY
cryo-EM buffer
PBS；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
2 second blot；154 K；Cryogen ETHANE；Blotted for 2 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.70 Å |
| 3JBD Complex of poliovirus with VHH PVSP6A Deposited 2015-08-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–578（237 aa）
Fragment：UNP residues 342-578
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 6 |
ELECTRON MICROSCOPY
cryo-EM buffer
PBS；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
2 second blot；154 K；Cryogen ETHANE；Blotted for 2 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.70 Å |
| 3JBD Complex of poliovirus with VHH PVSP6A Deposited 2015-08-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–578（237 aa）
Fragment：UNP residues 342-578
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
PBS；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
2 second blot；154 K；Cryogen ETHANE；Blotted for 2 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.70 Å |
| 3JBE Complex of poliovirus with VHH PVSS8A Deposited 2015-08-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–578（237 aa）
Fragment：UNP residues 342-578
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 60 |
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.20 Å |
| 3JBE Complex of poliovirus with VHH PVSS8A Deposited 2015-08-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–578（237 aa）
Fragment：UNP residues 342-578
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.20 Å |
| 3JBE Complex of poliovirus with VHH PVSS8A Deposited 2015-08-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–578（237 aa）
Fragment：UNP residues 342-578
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 5 |
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.20 Å |
| 3JBE Complex of poliovirus with VHH PVSS8A Deposited 2015-08-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–578（237 aa）
Fragment：UNP residues 342-578
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 6 |
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.20 Å |
| 3JBE Complex of poliovirus with VHH PVSS8A Deposited 2015-08-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–578（237 aa）
Fragment：UNP residues 342-578
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.20 Å |
| 3JBF Complex of poliovirus with VHH PVSP19B Deposited 2015-08-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–578（237 aa）
Fragment：UNP residues 342-578
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 60 |
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.60 Å |
| 3JBF Complex of poliovirus with VHH PVSP19B Deposited 2015-08-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–578（237 aa）
Fragment：UNP residues 342-578
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.60 Å |
| 3JBF Complex of poliovirus with VHH PVSP19B Deposited 2015-08-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–578（237 aa）
Fragment：UNP residues 342-578
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 5 |
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.60 Å |
| 3JBF Complex of poliovirus with VHH PVSP19B Deposited 2015-08-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–578（237 aa）
Fragment：UNP residues 342-578
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 6 |
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.60 Å |
| 3JBF Complex of poliovirus with VHH PVSP19B Deposited 2015-08-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–578（237 aa）
Fragment：UNP residues 342-578
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 4.60 Å |
| 3JBG Complex of poliovirus with VHH PVSS21E Deposited 2015-08-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–578（237 aa）
Fragment：UNP residues 342-578
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 60 |
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 3.80 Å |
| 3JBG Complex of poliovirus with VHH PVSS21E Deposited 2015-08-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–578（237 aa）
Fragment：UNP residues 342-578
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 3.80 Å |
| 3JBG Complex of poliovirus with VHH PVSS21E Deposited 2015-08-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–578（237 aa）
Fragment：UNP residues 342-578
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 5 |
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 3.80 Å |
| 3JBG Complex of poliovirus with VHH PVSS21E Deposited 2015-08-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–578（237 aa）
Fragment：UNP residues 342-578
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 6 |
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 3.80 Å |
| 3JBG Complex of poliovirus with VHH PVSS21E Deposited 2015-08-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–578（237 aa）
Fragment：UNP residues 342-578
Chain 4
2–69（68 aa）
Fragment：UNP residues 2-69
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | PLM PALMITIC ACID × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
145 mM NaCl, 50 mM Na2HPO4.12H2O；pH 7.4；145 mM NaCl, 50 mM Na2HPO4.12H2O
cryo-EM vitrification conditions
4 second blot；154 K；Cryogen ETHANE；Blotted for 4 seconds before plunging into liquid ethane (homemade plunger).
|
Resolution 3.80 Å |
| 4DCD 1.6A resolution structure of PolioVirus 3C Protease Containing a covalently bound dipeptidyl inhibitor Deposited 2012-01-17 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1566–1748（183 aa）
Fragment：unp residues 1566-1748
|
Not recorded | DTT 2,3-DIHYDROXY-1,4-DITHIOBUTANE × 1 K36 (1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid × 1 SO4 SULFATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 6.5；298 K；30% (w/v) PEG 5000 MME, 100 mM MES, 200 mM ammonium sulfate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 1.69 Å R-free 0.189 |
| 4K4S Poliovirus polymerase elongation complex (r3_form) Deposited 2013-04-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein–RNA Monomer；Protein × 1 PDB declaration: tetrameric |
Chain A
1749–2209（461 aa）
Fragment：unp residues 1749-2209
|
Mutation：L446D | ZN ZINC ION × 1 GOL GLYCEROL × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；289 K；sitting drop, temperature 289K, VAPOR DIFFUSION, SITTING DROP
|
Resolution 2.40 Å R-free 0.245 |
| 4K4S Poliovirus polymerase elongation complex (r3_form) Deposited 2013-04-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein–RNA Monomer；Protein × 1 PDB declaration: tetrameric |
Chain E
1749–2209（461 aa）
Fragment：unp residues 1749-2209
|
Mutation：L446D | ZN ZINC ION × 1 GOL GLYCEROL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；289 K；sitting drop, temperature 289K, VAPOR DIFFUSION, SITTING DROP
|
Resolution 2.40 Å R-free 0.245 |
| 4K4T Poliovirus polymerase elongation complex (r4_form) Deposited 2013-04-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein–RNA Monomer；Protein × 1 PDB declaration: tetrameric |
Chain A
1749–2209（461 aa）
Fragment：unp residues 1749-2209
|
Mutation：L446D | GOL GLYCEROL × 2 ZN ZINC ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；289 K；0.16 M MgCl2, 0.08 M Tris-HCl, 24% (w/v) PEG 4000, 20% (v/v) glycerol and directly frozen for data collection , VAPOR DIFFUSION, SITTING DROP, temperature 289K
|
Resolution 2.75 Å R-free 0.262 |
| 4K4T Poliovirus polymerase elongation complex (r4_form) Deposited 2013-04-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein–RNA Monomer；Protein × 1 PDB declaration: tetrameric |
Chain E
1749–2209（461 aa）
Fragment：unp residues 1749-2209
|
Mutation：L446D | GOL GLYCEROL × 2 ZN ZINC ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；289 K；0.16 M MgCl2, 0.08 M Tris-HCl, 24% (w/v) PEG 4000, 20% (v/v) glycerol and directly frozen for data collection , VAPOR DIFFUSION, SITTING DROP, temperature 289K
|
Resolution 2.75 Å R-free 0.262 |
| 4K4U Poliovirus polymerase elongation complex (r5_form) Deposited 2013-04-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein–RNA Monomer；Protein × 1 PDB declaration: tetrameric |
Chain A
1749–2209（461 aa）
Fragment：unp residues 1749-2209
|
Mutation：L446D, C290M | SO4 SULFATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；289 K；4.8%(v/v) isopropanol, 0.096 M tacsimate (Hampton Research), pH 8.5-9.0, 1.92-1.95 M ammonium sulfate, and 10-11%(v/v) glycerol and then gradually exchanged into a cryo stabilizer solution containing 4.8%(v/v) isopropanol, 0.096 M tacsimate, 1.95 M ammonium sulfate and 19-27%(v/v) xylitol prior to freezing, VAPOR DIFFUSION, SITTING DROP, temperature 289K
|
Resolution 2.85 Å R-free 0.276 |
| 4K4U Poliovirus polymerase elongation complex (r5_form) Deposited 2013-04-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein–RNA Monomer；Protein × 1 PDB declaration: tetrameric |
Chain E
1749–2209（461 aa）
Fragment：unp residues 1749-2209
|
Mutation：L446D, C290M | SO4 SULFATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；289 K；4.8%(v/v) isopropanol, 0.096 M tacsimate (Hampton Research), pH 8.5-9.0, 1.92-1.95 M ammonium sulfate, and 10-11%(v/v) glycerol and then gradually exchanged into a cryo stabilizer solution containing 4.8%(v/v) isopropanol, 0.096 M tacsimate, 1.95 M ammonium sulfate and 19-27%(v/v) xylitol prior to freezing, VAPOR DIFFUSION, SITTING DROP, temperature 289K
|
Resolution 2.85 Å R-free 0.276 |
| 4K4V Poliovirus polymerase elongation complex (r5+1_form) Deposited 2013-04-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Monomer；Protein × 1 PDB declaration: trimeric |
Chain A
1749–2209（461 aa）
Fragment：unp residues 1749-2209
|
Mutation：L446D, C290M | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；289 K；4.8%(v/v) isopropanol, 0.096 M tacsimate (Hampton Research), 1.92-1.95 M ammonium sulfate, and 10-11%(v/v) glycerol and then gradually exchanged into a cryo stabilizer solution containing 4.8%(v/v) isopropanol, 0.096 M tacsimate, 1.95 M ammonium sulfate and 19-27% (v/v) xylitol with dCTP prior to freezing, pH pH 8.5-9.0, VAPOR DIFFUSION, SITTING DROP, temperature 289K
|
Resolution 2.63 Å R-free 0.273 |
| 4K4V Poliovirus polymerase elongation complex (r5+1_form) Deposited 2013-04-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Monomer；Protein × 1 PDB declaration: trimeric |
Chain E
1749–2209（461 aa）
Fragment：unp residues 1749-2209
|
Mutation：L446D, C290M | SO4 SULFATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；289 K；4.8%(v/v) isopropanol, 0.096 M tacsimate (Hampton Research), 1.92-1.95 M ammonium sulfate, and 10-11%(v/v) glycerol and then gradually exchanged into a cryo stabilizer solution containing 4.8%(v/v) isopropanol, 0.096 M tacsimate, 1.95 M ammonium sulfate and 19-27% (v/v) xylitol with dCTP prior to freezing, pH pH 8.5-9.0, VAPOR DIFFUSION, SITTING DROP, temperature 289K
|
Resolution 2.63 Å R-free 0.273 |
| 4K4W Poliovirus polymerase elongation complex (r5+2_form) Deposited 2013-04-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein–RNA Monomer；Protein × 1 PDB declaration: trimeric |
Chain A
1749–2209（461 aa）
Fragment：unp residues 1749-2209
|
Mutation：L446D, C290A | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；289 K；4.8%(v/v) isopropanol, 0.096 M tacsimate, 1.92-1.95 M ammonium sulfate, and 10-11%(v/v) glycerol and then gradually exchanged into a cryo stabilizer solution containing 4.8%(v/v) isopropanol, 0.096 M tacsimate, 1.95 M ammonium sulfate and 19-27%(v/v) xylitol with CTP prior to freezing, VAPOR DIFFUSION, SITTING DROP, temperature 289K
|
Resolution 2.69 Å R-free 0.256 |
| 4K4W Poliovirus polymerase elongation complex (r5+2_form) Deposited 2013-04-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein–RNA Monomer；Protein × 1 PDB declaration: trimeric |
Chain E
1749–2209（461 aa）
Fragment：unp residues 1749-2209
|
Mutation：L446D, C290A | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；289 K；4.8%(v/v) isopropanol, 0.096 M tacsimate, 1.92-1.95 M ammonium sulfate, and 10-11%(v/v) glycerol and then gradually exchanged into a cryo stabilizer solution containing 4.8%(v/v) isopropanol, 0.096 M tacsimate, 1.95 M ammonium sulfate and 19-27%(v/v) xylitol with CTP prior to freezing, VAPOR DIFFUSION, SITTING DROP, temperature 289K
|
Resolution 2.69 Å R-free 0.256 |
| 4NLO Poliovirus Polymerase - C290I Loop Mutant Deposited 2013-11-14 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1749–2209（461 aa）
|
Mutation：C290I, L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) | ACY ACETIC ACID × 5 1PE PENTAETHYLENE GLYCOL × 2 NA SODIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.20 Å R-free 0.251 |
| 4NLP Poliovirus Polymerase - C290V Loop Mutant Deposited 2013-11-14 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1749–2209（461 aa）
|
Mutation：C290V, L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) | ACY ACETIC ACID × 5 1PE PENTAETHYLENE GLYCOL × 2 NA SODIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7；289 K；Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid, and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.20 Å R-free 0.248 |
| 4NLQ Poliovirus Polymerase - C290F Loop Mutant Deposited 2013-11-14 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1749–2209（461 aa）
|
Mutation：C290F, L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) | ACY ACETIC ACID × 7 1PE PENTAETHYLENE GLYCOL × 2 NA SODIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7；289 K；Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.30 Å R-free 0.245 |
| 4NLR Poliovirus Polymerase - C290S Loop Mutant Deposited 2013-11-14 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1749–2209（461 aa）
|
Mutation：C290S, L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) | ACY ACETIC ACID × 6 1PE PENTAETHYLENE GLYCOL × 2 NA SODIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7；289 K；Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.00 Å R-free 0.240 |
| 4NLS Poliovirus Polymerase - S288A Loop Mutant Deposited 2013-11-14 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1749–2209（461 aa）
|
Mutation：S288A (+L446D,R455D in Thumb) Non-standard monomer：Yes (specific site not provided by mmCIF) | ACY ACETIC ACID × 5 1PE PENTAETHYLENE GLYCOL × 3 NA SODIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.00 Å R-free 0.256 |
| 4NLT Poliovirus Polymerase - S291P Loop Mutant Deposited 2013-11-14 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1749–2209（461 aa）
|
Mutation：S291P , L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) | ACY ACETIC ACID × 5 1PE PENTAETHYLENE GLYCOL × 4 NA SODIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
Hanging drop；pH 7；289 K；Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid (pH 7.0) and 2 mM DTT, Hanging drop, temperature 289K
|
Resolution 2.50 Å R-free 0.256 |
| 4NLU Poliovirus Polymerase - G289A Loop Mutant Deposited 2013-11-14 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1749–2209（461 aa）
|
Mutation：G289A, L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) | ACY ACETIC ACID × 6 1PE PENTAETHYLENE GLYCOL × 2 NA SODIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid, and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.10 Å R-free 0.246 |
| 4NLV Poliovirus Polymerase - G289A/C290F Loop Mutant Deposited 2013-11-14 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1749–2209（461 aa）
|
Mutation：G289A,C290F, L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) | ACY ACETIC ACID × 8 1PE PENTAETHYLENE GLYCOL × 2 NA SODIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7；289 K；Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid, 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.30 Å R-free 0.240 |
| 4NLW Poliovirus Polymerase - G289A/C290I Loop Mutant Deposited 2013-11-14 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1749–2209（461 aa）
|
Mutation：G289A, C290I, L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) | ACY ACETIC ACID × 5 1PE PENTAETHYLENE GLYCOL × 2 NA SODIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7；289 K；Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.10 Å R-free 0.242 |
| 4NLX Poliovirus Polymerase - G289A/C290V Loop Mutant Deposited 2013-11-14 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1749–2209（461 aa）
|
Mutation：G289A, C290V, L446D, 455D Non-standard monomer：Yes (specific site not provided by mmCIF) | ACY ACETIC ACID × 5 1PE PENTAETHYLENE GLYCOL × 2 NA SODIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 7；289 K；Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.60 Å R-free 0.236 |
| 4NLY Poliovirus Polymerase - C290E Loop Mutant Deposited 2013-11-14 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1749–2209（461 aa）
|
Mutation：C290E, L446D, R455D Non-standard monomer：Yes (specific site not provided by mmCIF) | ACY ACETIC ACID × 5 1PE PENTAETHYLENE GLYCOL × 2 NA SODIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7；289 K；Grown in sodium acetate, cacodylate, DTT. Transferred to 250 mM sodium acetate, 30% (w/v) PEG-400, 0.1 M cacodylic acid and 2 mM DTT, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.30 Å R-free 0.239 |
| 4R0E Crystal Structure of the Poliovirus RNA-Dependent RNA Polymerase Low-Fidelity Mutant 3Dpol H273R Deposited 2014-07-30 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1749–2209（461 aa）
|
Mutation：H273R, L446D, R455D | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION；pH 7；293 K；Mixed equal volumes of protein 10mg/ml in buffer (5mM Tris pH 7.5, 200mM NaCl, 0.1mM EDTA, 2mM DTT) and reservoir solution (2M Na Acetate, 0.1 M Na Cacodylate pH 6.8) prior to vapor diffusion, VAPOR DIFFUSION, temperature 293K
|
Resolution 3.00 Å R-free 0.218 |
| 5KTZ expanded poliovirus in complex with VHH 12B Deposited 2016-07-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 240 PDB declaration: 240-meric |
Chain 1
636–858（223 aa）
Fragment：UNP residues 636-858
Chain 2
70–338（269 aa）
Fragment：UNP residues 70-338
Chain 3
342–572（231 aa）
Fragment：UNP residues 342-572
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.30 Å |
| 5KTZ expanded poliovirus in complex with VHH 12B Deposited 2016-07-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 4 PDB declaration: tetrameric |
Chain 1
636–858（223 aa）
Fragment：UNP residues 636-858
Chain 2
70–338（269 aa）
Fragment：UNP residues 70-338
Chain 3
342–572（231 aa）
Fragment：UNP residues 342-572
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.30 Å |
| 5KTZ expanded poliovirus in complex with VHH 12B Deposited 2016-07-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 20 PDB declaration: eicosameric |
Chain 1
636–858（223 aa）
Fragment：UNP residues 636-858
Chain 2
70–338（269 aa）
Fragment：UNP residues 70-338
Chain 3
342–572（231 aa）
Fragment：UNP residues 342-572
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.30 Å |
| 5KTZ expanded poliovirus in complex with VHH 12B Deposited 2016-07-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 24 PDB declaration: 24-meric |
Chain 1
636–858（223 aa）
Fragment：UNP residues 636-858
Chain 2
70–338（269 aa）
Fragment：UNP residues 70-338
Chain 3
342–572（231 aa）
Fragment：UNP residues 342-572
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.30 Å |
| 5KTZ expanded poliovirus in complex with VHH 12B Deposited 2016-07-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 4 PDB declaration: tetrameric |
Chain 1
636–858（223 aa）
Fragment：UNP residues 636-858
Chain 2
70–338（269 aa）
Fragment：UNP residues 70-338
Chain 3
342–572（231 aa）
Fragment：UNP residues 342-572
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.30 Å |
| 5KU0 expanded poliovirus in complex with VHH 17B Deposited 2016-07-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 240 PDB declaration: 240-meric |
Chain 1
636–858（223 aa）
Fragment：UNP reisdues 636-858
Chain 2
70–338（269 aa）
Fragment：UNP residues 70-338
Chain 3
342–572（231 aa）
Fragment：UNP residues 342-571
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.30 Å |
| 5KU0 expanded poliovirus in complex with VHH 17B Deposited 2016-07-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 4 PDB declaration: tetrameric |
Chain 1
636–858（223 aa）
Fragment：UNP reisdues 636-858
Chain 2
70–338（269 aa）
Fragment：UNP residues 70-338
Chain 3
342–572（231 aa）
Fragment：UNP residues 342-571
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.30 Å |
| 5KU0 expanded poliovirus in complex with VHH 17B Deposited 2016-07-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 20 PDB declaration: eicosameric |
Chain 1
636–858（223 aa）
Fragment：UNP reisdues 636-858
Chain 2
70–338（269 aa）
Fragment：UNP residues 70-338
Chain 3
342–572（231 aa）
Fragment：UNP residues 342-571
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.30 Å |
| 5KU0 expanded poliovirus in complex with VHH 17B Deposited 2016-07-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 24 PDB declaration: 24-meric |
Chain 1
636–858（223 aa）
Fragment：UNP reisdues 636-858
Chain 2
70–338（269 aa）
Fragment：UNP residues 70-338
Chain 3
342–572（231 aa）
Fragment：UNP residues 342-571
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.30 Å |
| 5KU0 expanded poliovirus in complex with VHH 17B Deposited 2016-07-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 4 PDB declaration: tetrameric |
Chain 1
636–858（223 aa）
Fragment：UNP reisdues 636-858
Chain 2
70–338（269 aa）
Fragment：UNP residues 70-338
Chain 3
342–572（231 aa）
Fragment：UNP residues 342-571
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.30 Å |
| 5KU2 expanded poliovirus in complex with VHH 7A Deposited 2016-07-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 240 PDB declaration: 240-meric |
Chain 1
650–858（209 aa）
Fragment：UNP residues 650-858
Chain 2
70–337（268 aa）
Fragment：UNP residues 70-337
Chain 3
342–571（230 aa）
Fragment：UNP residues 342-571
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.30 Å |
| 5KU2 expanded poliovirus in complex with VHH 7A Deposited 2016-07-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 4 PDB declaration: tetrameric |
Chain 1
650–858（209 aa）
Fragment：UNP residues 650-858
Chain 2
70–337（268 aa）
Fragment：UNP residues 70-337
Chain 3
342–571（230 aa）
Fragment：UNP residues 342-571
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.30 Å |
| 5KU2 expanded poliovirus in complex with VHH 7A Deposited 2016-07-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 20 PDB declaration: eicosameric |
Chain 1
650–858（209 aa）
Fragment：UNP residues 650-858
Chain 2
70–337（268 aa）
Fragment：UNP residues 70-337
Chain 3
342–571（230 aa）
Fragment：UNP residues 342-571
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.30 Å |
| 5KU2 expanded poliovirus in complex with VHH 7A Deposited 2016-07-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 24 PDB declaration: 24-meric |
Chain 1
650–858（209 aa）
Fragment：UNP residues 650-858
Chain 2
70–337（268 aa）
Fragment：UNP residues 70-337
Chain 3
342–571（230 aa）
Fragment：UNP residues 342-571
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.30 Å |
| 5KU2 expanded poliovirus in complex with VHH 7A Deposited 2016-07-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 4 PDB declaration: tetrameric |
Chain 1
650–858（209 aa）
Fragment：UNP residues 650-858
Chain 2
70–337（268 aa）
Fragment：UNP residues 70-337
Chain 3
342–571（230 aa）
Fragment：UNP residues 342-571
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.30 Å |
| 5KWL expanded poliovirus in complex with VHH 10E Deposited 2016-07-18 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 240 PDB declaration: 240-meric |
Chain 1
650–858（209 aa）
Fragment：UNP residues 650-858
Chain 2
70–337（268 aa）
Fragment：UNP residues 70-337
Chain 3
342–571（230 aa）
Fragment：UNP residues 342-571
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.80 Å |
| 5KWL expanded poliovirus in complex with VHH 10E Deposited 2016-07-18 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 4 PDB declaration: tetrameric |
Chain 1
650–858（209 aa）
Fragment：UNP residues 650-858
Chain 2
70–337（268 aa）
Fragment：UNP residues 70-337
Chain 3
342–571（230 aa）
Fragment：UNP residues 342-571
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.80 Å |
| 5KWL expanded poliovirus in complex with VHH 10E Deposited 2016-07-18 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 20 PDB declaration: eicosameric |
Chain 1
650–858（209 aa）
Fragment：UNP residues 650-858
Chain 2
70–337（268 aa）
Fragment：UNP residues 70-337
Chain 3
342–571（230 aa）
Fragment：UNP residues 342-571
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.80 Å |
| 5KWL expanded poliovirus in complex with VHH 10E Deposited 2016-07-18 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 24 PDB declaration: 24-meric |
Chain 1
650–858（209 aa）
Fragment：UNP residues 650-858
Chain 2
70–337（268 aa）
Fragment：UNP residues 70-337
Chain 3
342–571（230 aa）
Fragment：UNP residues 342-571
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.80 Å |
| 5KWL expanded poliovirus in complex with VHH 10E Deposited 2016-07-18 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 4 PDB declaration: tetrameric |
Chain 1
650–858（209 aa）
Fragment：UNP residues 650-858
Chain 2
70–337（268 aa）
Fragment：UNP residues 70-337
Chain 3
342–571（230 aa）
Fragment：UNP residues 342-571
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.80 Å |
| 5Z3Q Crystal Structure of a Soluble Fragment of Poliovirus 2C ATPase (2.55 Angstrom) Deposited 2018-01-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer；Protein × 4 PDB declaration: tetrameric |
Chain B
1243–1456（214 aa）
Fragment：UNP residues 1243-1456
Chain C
1243–1456（214 aa）
Fragment：UNP residues 1243-1456
Chain D
1243–1456（214 aa）
Fragment：UNP residues 1243-1456
Chain E
1243–1456（214 aa）
Fragment：UNP residues 1243-1456
|
Mutation：E207A, K209A,R149A Mutation：E207A, K209A,R149A Mutation：E207A, K209A,R149A Mutation：E207A, K209A,R149A | ZN ZINC ION × 4 PO4 PHOSPHATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 6.5；293 K；MgCl2 0.2M, MES 0.1M pH 6.5, 3%(v/v) PGE4000, Polypropylene glycol P 400 (9.2% v/v) , 0.5mM TECP HCl
|
Resolution 2.54 Å R-free 0.265 |
| 5Z3Q Crystal Structure of a Soluble Fragment of Poliovirus 2C ATPase (2.55 Angstrom) Deposited 2018-01-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1243–1456（214 aa）
Fragment：UNP residues 1243-1456
|
Mutation：E207A, K209A,R149A | ZN ZINC ION × 1 PO4 PHOSPHATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 6.5；293 K；MgCl2 0.2M, MES 0.1M pH 6.5, 3%(v/v) PGE4000, Polypropylene glycol P 400 (9.2% v/v) , 0.5mM TECP HCl
|
Resolution 2.54 Å R-free 0.265 |
| 5Z3Q Crystal Structure of a Soluble Fragment of Poliovirus 2C ATPase (2.55 Angstrom) Deposited 2018-01-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain H
1243–1456（214 aa）
Fragment：UNP residues 1243-1456
|
Mutation：E207A, K209A,R149A | ZN ZINC ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 6.5；293 K；MgCl2 0.2M, MES 0.1M pH 6.5, 3%(v/v) PGE4000, Polypropylene glycol P 400 (9.2% v/v) , 0.5mM TECP HCl
|
Resolution 2.54 Å R-free 0.265 |
| 6HLV Crystal structure of human ACBD3 GOLD domain in complex with 3A protein of poliovirus-1 (L24A mutant) Deposited 2018-09-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric |
Chain B
1457–1514（58 aa）
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；291 K；12,5% w/v PEG 4000, 20% v/v 1,2,6-hexanetriol, 4% v/v tert-butanol, 1 mM rubidium chloride, 1 mM strontium chloride, 1 mM cesium acetate, 1 mM barium acetate, 100 mM GlyGly/AMPD pH 8.5
|
Resolution 2.50 Å R-free 0.241 |
| 6P9O Poliovirus 135S-like expanded particle in complex with a monoclonal antibody directed against the N-terminal extension of capsid protein VP1 Deposited 2019-06-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 180 PDB declaration: 180-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5；phosphate-buffered saline
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å |
| 6P9O Poliovirus 135S-like expanded particle in complex with a monoclonal antibody directed against the N-terminal extension of capsid protein VP1 Deposited 2019-06-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5；phosphate-buffered saline
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å |
| 6P9O Poliovirus 135S-like expanded particle in complex with a monoclonal antibody directed against the N-terminal extension of capsid protein VP1 Deposited 2019-06-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 15 PDB declaration: pentadecameric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5；phosphate-buffered saline
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å |
| 6P9O Poliovirus 135S-like expanded particle in complex with a monoclonal antibody directed against the N-terminal extension of capsid protein VP1 Deposited 2019-06-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 18 PDB declaration: octadecameric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5；phosphate-buffered saline
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å |
| 6P9O Poliovirus 135S-like expanded particle in complex with a monoclonal antibody directed against the N-terminal extension of capsid protein VP1 Deposited 2019-06-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5；phosphate-buffered saline
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å |
| 6P9W Poliovirus (Type 1 Mahoney), receptor catalysed 135S particle map Deposited 2019-06-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 180 PDB declaration: 180-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5；20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å |
| 6P9W Poliovirus (Type 1 Mahoney), receptor catalysed 135S particle map Deposited 2019-06-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5；20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å |
| 6P9W Poliovirus (Type 1 Mahoney), receptor catalysed 135S particle map Deposited 2019-06-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 15 PDB declaration: pentadecameric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5；20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å |
| 6P9W Poliovirus (Type 1 Mahoney), receptor catalysed 135S particle map Deposited 2019-06-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 18 PDB declaration: octadecameric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5；20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å |
| 6P9W Poliovirus (Type 1 Mahoney), receptor catalysed 135S particle map Deposited 2019-06-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5；20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å |
| 6PSZ Poliovirus (Type 1 Mahoney), heat-catalysed 135S particle Deposited 2019-07-14 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 180 PDB declaration: 180-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5；20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å |
| 6PSZ Poliovirus (Type 1 Mahoney), heat-catalysed 135S particle Deposited 2019-07-14 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5；20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å |
| 6PSZ Poliovirus (Type 1 Mahoney), heat-catalysed 135S particle Deposited 2019-07-14 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 15 PDB declaration: pentadecameric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5；20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å |
| 6PSZ Poliovirus (Type 1 Mahoney), heat-catalysed 135S particle Deposited 2019-07-14 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 18 PDB declaration: octadecameric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5；20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å |
| 6PSZ Poliovirus (Type 1 Mahoney), heat-catalysed 135S particle Deposited 2019-07-14 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5；20 mM Tris-HCl, pH 7.5 + 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å |
| 6Q0B Poliovirus (Type 1 Mahoney), receptor-catalysed 135S particle incubated with anti-VP1 mAb at RT for 1 hr Deposited 2019-08-01 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 300 PDB declaration: 300-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–579（238 aa）
Fragment：UNP residues 342-579
Chain 4
2–70（69 aa）
Fragment：UNP residues 2-70
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5；20 mM Tris-HCl, pH 7.5, 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å |
| 6Q0B Poliovirus (Type 1 Mahoney), receptor-catalysed 135S particle incubated with anti-VP1 mAb at RT for 1 hr Deposited 2019-08-01 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–579（238 aa）
Fragment：UNP residues 342-579
Chain 4
2–70（69 aa）
Fragment：UNP residues 2-70
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5；20 mM Tris-HCl, pH 7.5, 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å |
| 6Q0B Poliovirus (Type 1 Mahoney), receptor-catalysed 135S particle incubated with anti-VP1 mAb at RT for 1 hr Deposited 2019-08-01 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 25 PDB declaration: 25-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–579（238 aa）
Fragment：UNP residues 342-579
Chain 4
2–70（69 aa）
Fragment：UNP residues 2-70
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5；20 mM Tris-HCl, pH 7.5, 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å |
| 6Q0B Poliovirus (Type 1 Mahoney), receptor-catalysed 135S particle incubated with anti-VP1 mAb at RT for 1 hr Deposited 2019-08-01 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–579（238 aa）
Fragment：UNP residues 342-579
Chain 4
2–70（69 aa）
Fragment：UNP residues 2-70
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5；20 mM Tris-HCl, pH 7.5, 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å |
| 6Q0B Poliovirus (Type 1 Mahoney), receptor-catalysed 135S particle incubated with anti-VP1 mAb at RT for 1 hr Deposited 2019-08-01 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 5 PDB declaration: pentameric |
Chain 1
580–881（302 aa）
Fragment：UNP residues 580-881
Chain 2
70–341（272 aa）
Fragment：UNP residues 70-341
Chain 3
342–579（238 aa）
Fragment：UNP residues 342-579
Chain 4
2–70（69 aa）
Fragment：UNP residues 2-70
|
Non-standard monomer：Yes (specific site not provided by mmCIF) | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5；20 mM Tris-HCl, pH 7.5, 2 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å |
| 8E8L 9H2 Fab-poliovirus 1 complex Deposited 2022-08-25 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 360 PDB declaration: 360-meric |
Chain 1
600–881（282 aa）
Chain 2
77–341（265 aa）
Chain 4
2–69（68 aa）
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.13 Å |
| 8E8L 9H2 Fab-poliovirus 1 complex Deposited 2022-08-25 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 6 PDB declaration: hexameric |
Chain 1
600–881（282 aa）
Chain 2
77–341（265 aa）
Chain 4
2–69（68 aa）
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.13 Å |
| 8E8L 9H2 Fab-poliovirus 1 complex Deposited 2022-08-25 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 30 PDB declaration: 30-meric |
Chain 1
600–881（282 aa）
Chain 2
77–341（265 aa）
Chain 4
2–69（68 aa）
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.13 Å |
| 8E8L 9H2 Fab-poliovirus 1 complex Deposited 2022-08-25 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 36 PDB declaration: 36-meric |
Chain 1
600–881（282 aa）
Chain 2
77–341（265 aa）
Chain 4
2–69（68 aa）
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.13 Å |
| 8E8L 9H2 Fab-poliovirus 1 complex Deposited 2022-08-25 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 6 PDB declaration: hexameric |
Chain 1
600–881（282 aa）
Chain 2
77–341（265 aa）
Chain 4
2–69（68 aa）
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.13 Å |
| 9EYY Poliovirus type 1 (strain Mahoney) native conformation stabilised virus-like particle (PV1 SC6b) from a yeast expression system. Deposited 2024-04-09 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer；Protein × 180 PDB declaration: 180-meric |
Chain A
580–881（302 aa）
Chain B
2–341（340 aa）
Chain C
342–579（238 aa）
|
Mutation：VP1 H248P Mutation：VP2 T94A, VP2 D126E, VP4 R18G Mutation：VP3 L119M, VP3 Q178L | PLM PALMITIC ACID × 60 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7；1 x DPBS, 20 mM EDTA, pH 7.0
cryo-EM vitrification conditions
Cryogen ETHANE-PROPANE；3-4 ul of sample double blotted for 3.5 seconds with -15 blot force on FEI Vitrobot mark IV.
|
Resolution 3.30 Å |
| 9EZ0 Poliovirus type 1 (strain Mahoney) expanded conformation stabilised virus-like particle (PV1 SC6b) from a yeast expression system. Deposited 2024-04-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer；Protein × 180 PDB declaration: 180-meric |
Chain A
580–881（302 aa）
Chain B
2–341（340 aa）
Chain C
342–579（238 aa）
|
Mutation：VP1 H248P Mutation：VP2 T94A, VP2 D126E, VP4 R18G Mutation：VP3 L119M, VP3 Q178L | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7；1 x DPBS, 20 mM EDTA, pH 7.0
cryo-EM vitrification conditions
Cryogen ETHANE-PROPANE；3-4 ul of sample double blotted for 3.5 seconds with -15 blot force on FEI Vitrobot mark IV.
|
Resolution 3.30 Å |
| 9F0K Poliovirus type 1 (strain Mahoney) expanded conformation stabilised virus-like particle (PV1 SC6b) from a mammalian expression system Deposited 2024-04-16 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer；Protein × 180 PDB declaration: 180-meric |
Chain A
580–881（302 aa）
Chain B
2–341（340 aa）
Chain C
342–579（238 aa）
|
Mutation：VP1 H248P Mutation：VP2 T25A, VP2 D57E, VP4 R18G Mutation：VP3 L119M, VP3 Q178L | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7；1 x DPBS, 20 mM EDTA, pH 7.0
cryo-EM vitrification conditions
Cryogen ETHANE-PROPANE；3-4 ul of sample double blotted for 3.5 seconds with -15 blot force on FEI Vitrobot mark IV.
|
Resolution 3.00 Å |
| 9F3Q Poliovirus type 1 (strain Mahoney) stabilised virus-like particle (PV1 SC6b) in complex with GPP3 and GSH. Deposited 2024-04-25 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer；Protein × 180 PDB declaration: 180-meric |
Chain A
580–881（302 aa）
Chain B
2–341（340 aa）
Chain C
342–579（238 aa）
|
Mutation：VP1 H248P Mutation：VP2 T25A, VP2 D57E, VP4 R18G Mutation：VP3 L119M, VP3 Q178L | YM2 1-[(3S)-5-[4-[(E)-ETHOXYIMINOMETHYL]PHENOXY]-3-METHYL-PENTYL]-3-PYRIDIN-4-YL-IMIDAZOLIDIN-2-ONE × 60 GSH Glutathione × 60 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7；1 x DPBS, 20 mM EDTA, pH 7.0
cryo-EM vitrification conditions
Cryogen ETHANE-PROPANE；3-4 ul of sample blotted for 3.5 seconds with -15 blot force on FEI Vitrobot mark IV.
|
Resolution 2.75 Å |
| 9FQ2 Poliovirus 3C protease in H32 spacegroup Deposited 2024-06-14 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1566–1748（183 aa）
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；293 K；Shotgun ECO screen, well B9
1.6M Sodium citrate tribasic dihydrate
|
Resolution 2.37 Å R-free 0.258 |
| 9FQ2 Poliovirus 3C protease in H32 spacegroup Deposited 2024-06-14 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain B
1566–1748（183 aa）
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；293 K；Shotgun ECO screen, well B9
1.6M Sodium citrate tribasic dihydrate
|
Resolution 2.37 Å R-free 0.258 |
| 9WAG Yeast-expressed polio type 1 expanded virus-like particles Deposited 2025-08-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer；Protein × 183 PDB declaration: 183-meric |
Chain A
580–881（302 aa）
Chain B
70–341（272 aa）
Chain C
342–579（238 aa）
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.95 Å |
| 9WAH Yeast-expressed polio type 1 stabilized virus-like particles Deposited 2025-08-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer；Protein × 240 PDB declaration: 240-meric |
Chain F
1–69（69 aa）
Chain H
70–341（272 aa）
Chain I
342–579（238 aa）
Chain J
580–881（302 aa）
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.43 Å |
| 9WAI Yeast-expressed polio type 1 stablized virus-like particles with 3G10 Fab Deposited 2025-08-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 714 PDB declaration: 1068-meric |
Chain B
70–341（272 aa）
Chain C
342–579（238 aa）
Chain D
580–881（302 aa）
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.60 Å |
80 other PDB entries and 246 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | POLG_POL1M |
| Isoform | — |
| PDB entities | 1, 2, 3, 4 |
| Chains and sequence ranges | Author chain 1； PDBConstruct 1–302； UniProt 580–881 Author chain 2； PDBConstruct 1–272； UniProt 70–341 Author chain 3； PDBConstruct 1–238； UniProt 342–579 Author chain 4； PDBConstruct 2–69； UniProt 2–69 |
